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Zusammenfassung 
 
Das adaptive Immunsystem gewährleistet mit seinem breiten Spektrum an 
Immunzellen und deren Rezeptoren eine effektive Bekämpfung von einer 
Vielzahl von Pathogenen. Die T-Zell Generierung, welche im Thymus 
stattfindet, durchläuft einer zweistufigen Selektion, welche für die 
immunologische Selbsttoleranz essentiell ist. Für diese strikte Kontrolle der 
beiden Selektionen spielen vor allem zwei große Zellpopulationen eine 
wichtige Rolle, die kortikalen thymischen-Epithel-Zellen (kTEZ) und die 
medullären thymischen-Epithel-Zellen (mTEZ). Für die Vorbeugung von 
Autoimmunreaktionen spielt die Einbindung der mTEZ eine entscheidende 
Rolle, da diese periphere Selbst-Antigene exprimieren und diese den 
reifenden T-Zellen präsentieren. Die bisherigen Kenntnisse beschreiben die 
jeweiligen Funktionen der kTEZ und mTEZ, die Entwicklung einer Stammzelle 
bis zur Entwicklung einer mTEZ, bis hin zu welche molekularen Mechanismen 
die Entwicklung beeinflussen, aber bislang nicht in kleinsten Details. Bisher 
wurde der Sprung einer nicht unreifen mTEZ zu einer maturierten mTEZ nicht 
hinzureichend charakterisiert. Vorausgegangene Forschungen haben gezeigt, 
dass in fötalen und embryonalen unreifen mTEZ vier Subpopulationen zu 
finden sind, welche in adulten mTEZ bisher nicht beschrieben wurden. Bisher 
wurde die Existenz einer Handvoll microRNAs (miRNA), die eine Rolle in 
mTEZ spielen, entdeckt, aber keine miRNAs entdeckt, die für die Entwicklung 
der unreifen mTEZ zu reifen mTEZ eine entscheidende Rolle spielen. Im 
Rahmen der Doktorarbeit wurden die vier Subpopulationen in adulten mTEZ 
mit Hilfe von miRNA und mRNA Genexpressionsanalysen charakterisiert. 
Dabei wurde folgende Entwicklungssequenz der vier Subpopulationen aus 
den unreifen mTEZ anhand der mRNA Genexpression ermittelt Sca-1 < DP < 
CD24 < DN. DN war laut den Analysen die Vorstufe von reifen mTEZ. 
Daraufhin wurden mit Hilfe verschiedener bioinformatischen Methoden 
miRNAs herausgefiltert, die für die Entwicklung der vier Subpopulationen eine 
entscheidende Rolle spielen. Diese miRNA wurden mit Hilfe eines anderen 
Mausmodels verifiziert, welche die dynamische Entwicklung der vier 
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Subpopulationen nachahmt. Darauffolgend wurden die potentiellen miRNAs in 
frisch isolierten unreifen mTEZ inhibiert oder überexprimiert um deren Einfluss 
bei der Entwicklung der vier Subpopulationen zu untersuchen. Am Ende 
haben wir 11 miRNAs gefunden, die eine funktionelle Rolle bei der Reifung 
der 4 Subgruppen spielen. Mit dieser Erkenntnis haben wir mRNA-
Interaktionspartner der miRNAs gesucht, die für diesen Entwicklungsprozess 
wichtig sind. Nachdem 35 mRNAs untersucht wurden, stachen am Ende vier 
miRNA-mRNA-Interaktionspaare hervor, die bisher nicht in mTEZ 
beschrieben wurden. Folgendes Interaktionspartner wurden gefunden: miR-
34a mit Foxp1, Mir-125b-5p mit Bak1 und Mapk14, miR-125a-3p mit Fam83e. 
Die Arbeit vervollständig das Wissen über die Entwicklungslinie der zuvor 
gefundenen vier Subpopulationen in adulten Mäusen und gibt Ausschluss 
über neue miRNA und mRNA- Interaktionspartnern, die bei der Entwicklung 
der vier Subpopulationen von Wichtigkeit sind. Darüberhinaus können diese 
Erkenntnisse auf den humanen Thymus und deren MTEZ Entwicklung 
übertragen werden und im Hinblick auf Thymus-Regeneration eine äußerst 
wichtige Rolle spielen, vor allem nach Chemotherapie und 
Organtransplantationen.  
  
Summary	
5	
Summary 
 
The adaptive immune system with its diversity of immune cells and their 
receptors allows an effective fight against a plethora of pathogens. The 
development of T cells is taking place in the thymus, where it undergoes two 
selections that is immensely important to ensure self-tolerance. For those two 
strictly regulated selection processes there are two major cell components 
being responsible for that called cortical thymic epithelial cells (cTEC) and 
medullary thymic epithelial cells (mTEC). MTECs are playing an important role 
for the prevention of autoimmune diseases as they express self-antigens to 
the maturing T cells. The current knowledge describes basically the function 
of cTECs and mTECs, the development of a stem cell to mTEC, the 
involvement of molecular mechanisms which influences the development of 
thymus and mTECs, still not in every single details. To date molecular details 
are still missing how an immature mTEC develops to a mature mTEC, 
especially molecular mechanisms, which influence the maturation and what 
controls each single step to its final maturation. Previous researches have 
found in the immature mTECs four new subpopulations present in fetal and 
embryonic mTECs, which have not been shown in adult mice. Until now only 
a handful of microRNAs (miRNAs) have been found to play a role in mTECs, 
but no miRNAs have been founds to play an active role in the maturation 
process of mTECs. The scope of this doctorate thesis was to characterise the 
four subpopulations in adult mice with the help of mRNA and miRNA 
microarray analyses. With the help of the mRNA gene arrays we could 
decipher a lineage sequence within the four subpopulations stating that Sca1 
as the most progenitor population Sca-1 < DP < CD24 < DN. According to the 
analyses DN was the closest cell population to mature mTECs, probably one 
step before coming a mature mTEC. Thereupon we used bioinformatics to 
filter the most prominent miRNAs, which might play an important role in the 
development of the four subpopulations. Those miRNAs were verified by 
using a SCID mouse model, which emulates the dynamic development of the 
four subpopulations. Subsequently we inhibited or overexpressed those 
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miRNA candidates in freshly isolated mTECs to see their influence of the 
development of the four subpopulations. At the end we found 11 promising 
miRNAs that play a role in the maturation of the four subgroups. This finding 
resulted in a deeper search for possible mRNA interaction partners for those 
miRNA candidates. After investigating 35 mRNAs we found 4 miRNA-mRNA 
interactions, which have not been described in the mTEC development 
before. Following miRNA-mRNA networks have been found: miR-34a 
interacts with Foxp1, Mir-125b-5p with Bak1 and Mapk14, miR-125a-3p with 
Fam83e. This thesis completes the understanding of the four subpopulations 
in adult mice as well discovered 4 new miRNA-mRNA interactions, which are 
important for the maturation of the four subpopulations. With this newly gained 
knowledge we can apply it to the human thymus and their mTEC development 
with the hope to boost the thymus function after chemotherapy and organ 
transplantations.  
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1 Introduction 
 
The immune system is crucial for the survival of an organism as it is 
responsible for the detection and elimination of pathogens. It can be divided 
into two mechanisms, the innate and adaptive immune responses. The innate 
or naïve immune response can be typed as a fast but not specific response 
while the adaptive response develops after birth and advances itself during 
encountering with pathogens and becomes very specific. The T lymphocytes, 
short T cells, are playing a central role in the adaptive immune response, 
which have the feature to recognise self and non-self antigens with the 
involvement of self-major histocompatibility complexes (MHC). A highly 
diverse repertoire of T cells, up to 108 different variations, is generated in the 
thymus. The thymus provides T cells a place to mature and ensures a strict 
control of T cell development and elimination in case of self-reactivity, thus 
providing self-tolerance in the periphery (Parkin and Cohen, 2001). The 
function of the thymus and its importance for the T cell immune response was 
discovered over 50 years ago (Miller 1961). Today we know that the thymus is 
the essential site of T cell lineage commitment, T cell repertoire generation 
and subsequent stringent selection of T cell receptor specificity.  
1.1 The evolution and development of the thymus 
The thymus is a primary lymphoid organ for the generation of a variety of T 
cell repertoire, which has been reported to be only present in jawed and non-
jawed vertebrates. Their numbers and positions can vary differently among 
species. In mammals the location of the thymus is located in the upper chest 
area and contains of two main lobes, where each lobe consists of plentiful 
lobules packed into a capsule. The architecture of the thymus can be 
separated into four compartments, which includes the sub-capsular area, the 
cortical-medullary junction (CMJ), the cortex and the medulla. Within the 
thymus different cell types are harboured in it, which includes cells from the 
lymphocyte lineage (T cells, NK cells and NKT cells), hematopoietic cells 
(dendritic cells, macrophages and B cells) and thymic stroma cells (thymic 
epithelial cells, fibroblasts and endothelial cells) (Boyd et al. 1993). The 
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thymic epithelial cell (TEC) population can be divided into two components 
based on their function, morphology and antigen specific profiling, the cortical 
TECs (cTECs) and medullary TECs (mTECs). TECs have a very special 
morphology compared to typical epithelial cells, which are densely packed 
and mostly stratified on the basement membrane, while TECs are having a 
three-dimensional structure and different density packed areas (Brelinska and 
Warchol 1997, van Ewijik et al. 1999). Therefore the thymus with its unique 
feature provides an exceptional microenvironment for thymocyte migration, 
development and selection (Anderson and Jenkinson 2001, Prockop and 
Petrie 2000). 
1.1.2 The evolution of the adaptive immune system  
According to the history of evolution the adaptive immunity in vertebrates 
developed about 500 million years ago. It was the time frame where the 
occurrence of the thymus has been recorded, an organ that is responsible for 
the development of T cells. Both the anatomical position as well as the 
number of thymi differs from species to species (Rodewald 2008). Even 
though jawless and jawed vertebrates show similar features of an adaptive 
immunity such as the expression of a diversity of antigens, the mechanism of 
antigen composition vary in both families.  
1.2.1 The maturation of thymocytes in the thymus 
The differentiation and maturation processes of hematopoietic cell linages 
occur in two different sides, bone marrow and thymus. Whereas almost all 
linages differentiate and mature in the bone marrow, T cells are the only 
exception to develop in the thymus. T cells, which are still in the development 
and resided in the thymus, are called thymocytes. T cell progenitors are 
migrating from the bone marrow to the thymus and have to undergo a 
sequential of highly sophisticated and controlled selection processes. During 
those processes they encounter numerous cells of epithelial and 
mesenchymal origins, together these cells represent the thymic stroma and 
are resided in different compartments of the thymic microenvironment (Boyd 
1993, Klein and Kyewski, 2000). The thymus consists of different 
compartments with diverse functions where thymocytes have to migrate 
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through them during the maturation process: subcapsular zone, the outer area 
cortex and the inner region medulla that are separated by the cortico-
medullary junction. The developmental stage of thymocytes are categorized 
based on their expression levels of surface markers CD4 and CD8, which 
alters during the maturation starting from the immature stage CD4- CD8- 
double negative (DN) to CD4+ CD8+ double positive (DP) to be finally mature 
CD4+ or CD8+ single positive (SP) T cells (Rodewald 2007, Petrie and Zuniga-
Pflucker 2007).  
1.2.2 The selection of thymocytes and establishment of central 
tolerance 
The selection process all starts when T cell progenitors migrate to the thymus 
via blood vessels and arrive at the CMJ, from there they follow a chemokine 
gradient (CCR7, CCR9 and CXCR4) to enter the subcapsular area by passing 
by the cortex (Fig.1). In the subcapsular area thymocytes are starting to 
proliferate and remain in that area for several days (Benz et al. 2004, Plotkin 
et al. 2003). In that stage thymocytes are at their earliest immature stage and 
are described as DN as they do not express any CD4 and CD8 antigens. 
During that stage those DNs start to reshuffle their T cell receptor (TCR)α- 
and TCRβ-loci to generate unique and functioning αβ-TCRs by recombining 
V-, D and J gene cassettes in a stochastic mode to create diversities up to 
1015 unique receptors (von Boehmer et al. 1989, Ciofani and Zuniga-Pfluecker 
2007). Those who fail to reorder their T cell gene cassette properly will 
undergo apoptosis also named as death by neglect. Thymocytes are 
becoming DP after two weeks of entering the thymus and makes up to the 
biggest population of thymocytes in the thymus. DP thymocytes are harboured 
in the cortex compartment and only those DP thymocytes, which carry a 
functional TCR and have the ability to interact with peptide-MHC complexes 
presented by cTECs, in a particular affinity and/ or avidity will transcend the 
so-called positive selection process (Anderson et al. 1999, McCaughtry et al. 
2008). Before entering the medulla along another chemokine gradient (CCR7) 
those positively selected thymocytes with a TCR bound to a MHC class I 
molecule will become a CD8+ SP thymocyte, whereas TCR bound to a MHC 
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class II molecule will become a CD4+ SP thymocyte (Kurobe et al. 2006, 
Takahama 2006). In the medulla SP thymocytes come across with dendritic 
cells and mTECs and initiate the so-called negative selection process. This 
process is crucial to establish a central tolerance, as thymocytes with TCRs 
binding to self-peptides with a high affinity will undergo apoptosis. Those 
thymocytes with a medium binding capability will become regulatory T cells 
(Tregs). Non- to low binding of thymocytes to self-peptides will become naive 
T cells and will be released to the periphery. For a long time it was believed 
that the negative selection happens only in the medulla but recently a study 
has shown that the negative selection can also occur in parallel to the positive 
selection in the cortex initiated by cTECs and DCs (McCaughtry et al. 2008).  
 
Figure 1 The thymus compartment: Thymus consists of two compartments, cortex and medulla. 
Immature thymocytes are undergoing two selection progresses. Firstly positive selection 
occurs where only T cells with T cell receptors reactive to self-MHC proteins will pass.  Then 
they move forward to the medulla where the negative selection starts. Medullary thymic 
epithelial cells, short mTECs are harboring in the medulla. Their importance is to present self-
antigens to maturing T cells.  T cells with TCRs binding to self- antigens will undergo apoptosis. 
By eliminating auto-reactive T cells autoimmunity is prevented. And non-reactive T cells will be 
released to the periphery.  
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Addition to mTECs with the ability to present self-antigens to thymocytes, DCs 
in the thymus play also a central role for tolerance induction (Jenkinson et al. 
1992) as they have the feature to take up and present extracellular antigens 
(Kyewski et al. 1986, Klein et al. 2001). It has been reported that DC have the 
ability to take up self-antigens such as TRAs from mTECs and present them 
to developing thymocytes (Gellgos and Bevan 2004, Koble and Kyewski 
2009). As mTECs can represent only 1-3% of TRAs at a time, thus having 
mTECs as well as DCs to present self-antigens to maturing thymocytes, will 
increase the chances the encounter and capture of auto-reactive thymocytes, 
(Klein et al. 2009).  
1.2.3 The thymocyte selection model 
The selection process of TCRs is according to different models a process 
where certain levels of affinity and avidity between TCR and APC can 
determine the destiny of maturing thymocytes. Taking together the TCR 
affinity to self-peptide-MHC complex and the interaction with co-receptors on 
APCs, which determines the avidity, can resolve to the development of 
different cell types of T cells (Jameson and Bevan 1995). A thymocyte 
interaction with low avidity results favourably to a naïve T cell, while an 
interaction with higher avidity preferentially develops to a natural regulatory T 
cell. Developing thymocytes with a very high avidity leads to negative 
selection and will be induced to go to apoptosis (Hogquist 2001, Hogquist et 
al. 1994).  
1.2.4 The discrepancy between cTECs and mTECs 
A set of cells which play a major role in the T cell development and in the TCR 
repertoire selection process are called thymic epithelial cells (TECs). The 
development of TECs is regulated by two transcription factors Foxn1 and Aire, 
both are essential for their development and their functional maturation. TECs 
can be subdivided into two subgroups cortical thymic epithelial cells (cTECs) 
and medullary thymic epithelial cells (mTECs) and can be discriminated 
based on their expression of specific surface markers, their cell morphology 
and their location in the thymus. The progenitor of cTECs and mTECs derived 
from non-hematopoietic cells and are CD45 negative but epithelial cell 
1	Introduction	
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adhesion molecule 1 (EpCAM-1) positive. Furthermore cTECs are Ly51 
positive while mTECs are Ly51 negative. Whereas cTECs are Ulex 
eurpopaeus agglutinin-1 (UEA-1) negative, mTECs do express UEA-1. 
Another way to differentiate cTECs and mTECs are the expression of 
cytokeratins. cTECs express cytokeratin 8 (K8) and mTECs express 
cytokeratin 5 (K5). Studies have shown that TEC progenitors express both K8 
and K5 (Ucar et al. 2015, Bleul et al. 2006).   
1.2.5 The maturation of mTECs 
The developmental sequence of the MTEC development can be followed and 
determined by three markers such as CD80, MHC II and Aire. The immature 
mTECs show the following pattern CD80lowMHCIIlowAire-, during the 
intermediate stage they are CD80highMHCIIhighAire- and finally during the 
mature stage they are CD80highMHCIIhighAire+. After a certain period those 
mature mTECs become post mature mTECs and are 
CD80lowMHCIIlowAirelowIvl+ and can also be detected by adding an additional 
marker involucrin (Ivl) (Metzger et al. 2013). During the maturation of mTECs 
from immature to mature mTECs an increase of promiscuous gene 
expression (pGE) can be tracked and is been reported to have the highest 
degree of TRA expression and the most diversity of pGE (Fig.2). The unique 
feature of mTECs is the vast variety of TRAs presented to developing T cells 
to establish a central tolerance (Derbinski et al 2001, Klein et al. 2009).  
1	Introduction	
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Figure 2 The maturation of TECs: The stem cell develops further to a bipotent progenitor, 
dependent on the signals it can derive to  cTEC or mTEC. The immature mTEC undergoes 
maturation in different steps by expressing different expression markers such as Aire, CD80 
and MHCII.  
1.2.6 The crosstalk between developing thymocytes and thymus 
The function of the thymus is to generate functional T cells, which have the 
capacity to distinguish self and non-self. On the other hand SP thymocytes 
play a role in the organization of the medulla hence having an impact on the 
mTEC development. This interaction between thymocytes and thymus is 
called “thymic crosstalk” (Ewijk et al. 1994). Herby mice with the lack of 
functional B and T lymphocytes have a deficiency in the thymus development 
such as severe combined immunodeficiency (SCID) mice. Not only the size of 
the thymus is up to ten times smaller compared to its wild type but also the 
thymus organ structure is impaired. The CMJ is lacking and the compartments 
are disorganised. The numbers of TECs are decreased; particularly the 
number of mTECs is affected. T lymphocytes, which express whole CD3/TCR 
ab complexes, have the possibility to influence the maturation and 
organization of the medulla compartment by sending certain signals to 
mTECs such as RANK and CD40 signals, which have been shown in 
experiments to play a crucial role in the mTEC differentiation in adult mice. 
RANKL is expressed in CD4+ as well as in CD8+ thymocytes while CD40 is 
preferably expressed in CD4+ T cells (Hikosaka et al. 2008). The absence of 
1	Introduction	
14	
CD28 on CD4+ thymocytes, its binding partner CD80/86 on mTECs, is not 
causing major perturbation, but if CD28-CD80/86 and CD40/CD40L are 
inactivated a decrease of mTECs could be observed as dramatically as the 
total absence of CD4+ thymocytes. This demonstrates that the interplay 
between CD28-CD80/86 and CD40/CD40L play as well a profound role in the 
development of a proper medulla. Without the activation of those two 
signalling pathways SP T thymocytes are not properly screened for their auto 
reactivity as mTECs are not able to develop properly to provide proper pGE 
and TRA expressions thus it is more likely that autoimmunity occurs (Williams 
et al. 2014). A subset of Natural killer T cells (NKT), called invariant NKT cells 
(iNKT), also express RANKL, have been reported to play a role in the mTECs 
by their interplay with CD4+ T cells (White et al. 2014), (Bosma and Carroll, 
1991), (Lopes et al. 2015). Taking together the signalling mechanisms how 
mTECs are influenced by external signals to induce differentiation and 
medulla formation needs to be further elucidated. Experiments have shown 
that the thymus compartments especially the medulla and its mTECs can be 
restored by a bone marrow transplantation which gives the conclusion that 
hematopoietic cells are playing a crucial role in the proper medulla 
development and in turn a functional thymus is needed to provide a niche for 
developing T cells (Frenz et al. 1996). 
1.3 The Signalling pathways in TEC development 
The TEC development is stringently regulated by numerous pathways, which 
are known to play an essential role in the development of mTECs and 
thymocytes. One of the well-known pathways is the non-canonical nuclear 
factor κB (NF-κB) pathway that includes members of the tumour necrosis 
factor (TNF) receptor family involving RANK, lymphotoxin β receptor (LTβR) 
and CD40 (Akiyama et al. 2008). mTECs and thymocytes are partially 
communicating through (LTbR). Disruption occurs in the differentiation of 
mTECs, which will lead automatically to a reduced number of mTECs if LTβR 
is not present (Boehm et al. 2003). Disturbance of any of those above 
receptors or their downstream signalling molecules, such as the nuclear 
factor-κB-inducing kinase (Nik), which interacts with LTβR, can cause 
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autoimmunity as well as an impaired development of mTECs. Other 
components like IkB kinase α (IKKα), RelB and TNF receptor associated 
factor 6 (TRAF6) can also induce the production of autoantibodies due to the 
failure of developing functional mTECs (Burkly et al. 1995), (Akiyama et al. 
2005), (Kinoshita et al. 2006) (Thomas, 2005).  
Another important pathway, which influences the thymic architecture and 
mTEC development, is the signal transducer and activator of transcription 
(Stat) 3 signalling pathway. This molecule has been reported to play an 
essential role in cell proliferation, differentiation and cell survival by its anti-
apoptotic effect (Hirano et al. 2000, Damell JE Jr., 1997).  When deleting 
Stat3 in the thymus, a premature involution of the thymus occurs during 
adulthood, the cellularity got lost over time, no separation between cortex and 
medulla can be seen after 4 months, as well as its increased sensitivity to 
environmental stress; even though preadolescence did not shown any 
difference between control and Stat3-/- mice. Interestingly was to observe that 
thymocytes were not affected by the Stat3 deletion in spite of thymus 
hypoplasia but their numbers are decreased. Deletion of Stat3 also causes an 
expansion of the medulla, mostly mTEclow due to lower apoptotic effects in this 
subset, but a severe decline of the cortex. In overall it did not affect TRA 
expression or induce any autoimmune diseases compared to control mice. It 
is suggesting that Stat3 plays a role in the maintenance of thymus 
architecture especially for the formation of the medulla region as well as for 
the maintenance of mTECs but is unessential for the mTEC maturation. 
Stimulatory proteins, cytokines and growth factors mediate activation of Stat3. 
It has been reported that CD40 or epidermal growth factor (EGF) can mediate 
Stat3 activation and EGF-R has an influence in mTEC growth and medulla 
morphology in adult mice (Shigetoshi Sano et al. 2001), (Dakshayani Lomada 
et al. 2016), (Rumi Satoh et al. 2016).  
1.4 microRNAs and their influence in post-translational regulation  
MicroRNAs (miRNAs) are small RNAs, which have the capacity to regulate 
genes post-transcriptionally. They have been previously found in 
Caenorhabditis elegans (Pasquinelli and Ruvkun, 2002) and since their 
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discovery thousands of miRANs have been found in different species 
(Ambros, 2003), (Cai et al. 2009) and researchers have been trying to find 
their function in different cell types (Bartel, 2004), (He and Hannon, 2004). 
Their size range from 21-25 nucleotides, single stranded, mostly binds to the 
3’ untranslated region (3’UTR) of a mRNA that has a perfect or imperfect 
complementary sequence. So far only one miRNA and mRNA target has been 
reported to have a perfect complementarity. As the most of the cases is has 
multiple mismatches and several nucleotide bulges between the miRNA and 
its mRNA target (Pasquinelli, 2012). The function of miRNAs is diverse as it 
can degrade the mRNA target, can induce translational repression as well as 
deadenylation of the mRNA target strand. MiRNAs are fine-tuners and act 
accordingly to their cellular requirements. The canonical maturation of a 
functional miRNA starts with the transcription of the gene where the miRNA is 
located (Fig.3). In general the same cluster of miRNAs are co-transcribed and 
their functions can be similar or different even coming from the same miRNA 
cluster. Primary miRNA (pri-miRNA) is generated during the transcription by 
RNA polymerase (Pol II, occasionally Pol III) and cleaved by a complex called 
Drosha-DGCR8 to generate the precursor miRNA (pre-miRNA). Afterwards 
the pre-miRNA is transported with the help of Exportin-5 outside the nucleus 
to the cytoplasm. Another cleavage is followed by Dicer, which finally leads to 
a mature miRNA. The leading strand of the mature miRNA duplex is forming 
with Argonaute (Ago) proteins a RNA-induced silencing complex (RISC) that 
has the function to modulate the mRNA on a post-transcriptional level (Winter 
et al. 2009), (Ha and Kim, 2014). The other strand, which is the passenger 
strand, will be cleaved and degraded and not incorporated into RISC (Liu et 
al. 2013).  
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Figure 3 The maturation of miRNAs: The first step of the maturation starts in the nucleus and 
generates a pre-miRNA which then will be transported to the cytoplasm where the pre-miRNA 
undergoes several cleavage steps to become a mature miRNA. 
There is the non-canonical pathway how miRNAs can be loaded to the RISC 
complex without the involvement of dicer. This pathway is called the dicer-
independent miRNA biogenesis. It is believed that the pre-miRNA is loaded 
directly to Ago2, where the miRNA is sliced and unwound and later processed 
by so far unknown nucleases to become a functional mature miRNA (Yang 
and Lai, 2010), (Yang et al. 2012). Today there are many papers describing 
the involvement of miRNAs in cancer, cell regulation and differentiation 
(Mehta and Baltimore, 2016), (Baumjohann and Ansel, 2013) as well as in 
signalling pathways (Avraham and Yarden, 2012). The first alteration of 
miRNAs was found in 2002 in chronic lymphocytic leukemia (CLL). Since then 
miRNAs and their function and role in diseases have been elucidated and 
their use in the clinics to predict the outcome of a treatment or use miRNAs as 
biomarkers to diagnose a disease (Hayes et al. 2014).  
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The Notch signalling is also an important pathway in T cell lineage 
commitment and mTEC development (Feyerabend et al. 2009). The 
development of immature ab T cells to mature ab T cells is driven by Notch 
signalling, having its highest contribution in immature ab T cells, which 
includes early thymic progenitors, double-negative 2 (DN2) and DN3 
thymocytes. After the b-selection, which is after the DN3 stage, Notch 1 is 
downregulated and only a low expression is remained in double positive (DP) 
thymocytes (Radtke et al. 2013). Recently it has been found that expression 
of Notch 1, Notch 2, Notch 3, Hey 1 and Hey 2 are present in immature 
mTECs. Data are suggesting that downregulation of Notch 1 in mTECs have 
to be reduced to ensure a proper mTEC development. As a remaining 
activation of Notch 1 in mTECs will lead to a decrease of mature mTECs and 
an increase of immature mTECs (Goldfarb et al. 2016).  
1.4.1 The involvement of microRNAs in signalling pathways 
The major role of miRNAs is to regulate mRNA targets and influence their 
expression levels but they can also influence the cascade of a signalling 
pathway and act as a feedback loop (Taganov et al. 2006). High-throughput 
screenings have been done to reveal miRNAs in different signalling pathways, 
like the well-conserved NF-κB pathway (Yang and Wang, 2016) or the Notch 
signalling pathway  (Olarerin-George et al. 2013). MiRNAs discovered to play 
a role in NF-κB are for instance miR-125a and miR-125b which are constantly 
activating this pathway by repressing TNFα-induced protein 3 (TNFAIP3) 
which is known to be an important player in this signalling cascade (Kim et al. 
2012). Falling in a proper regulation of NF-κB signalling leads to diseases like 
incontinentia pigmenti, autoimmunity or cancer (Courtois and Giilmore, 2006). 
The Notch signalling pathway is involved in many biological processes like 
cell differentiation, development, survival and apoptosis. That is why miRNAs 
have a significant function in this part by fine-tuning the signals to assure a 
proper communication between cells. Prominent miRNAs have been 
discovered to play a crucial role in Notch such as miR-326, which interacts 
with Notch and other Notch proteins and acts as a feedback loop to maintain 
a proper communication (Kefas et al. 2009).  
1	Introduction	
19	
1.5 microRNAs in thymus development 
In the recent years researchers have focused on revealing microRNAs, which 
play a role in the T cell development and selection, thymus microenvironment 
and as well as differentiation and development of mTECs. As the thymus is 
proving T cell precursors a unique microenvironment to become mature T 
lymphocytes with the property to discriminate self and non-self to avoid 
autoimmune reactions, development of resided cells in the thymus as well as 
the microenvironment need to be regulated tightly to ensure a proper selection 
and maturation of T lymphocytes. Deletion of Dicer in Foxn1 Cre Dicerfl/fl mice 
results in the absence of mature miRNAs processed in the canonical pathway 
of Dicer-dependent miRNA biogenesis, which causes reduction of the thymus 
size as well as an impairment of thymus cellularity and development of T 
cells. Consequently the development of Foxp3 Treg is impaired and shows a 
lost of suppression function in vivo and mice are developing a lethal systemic 
autoimmune disease which resembles the FoxP3 knockout (KO) phenotype 
(Zhou et al. 2006). In aged Dicer deficient animals a complete absence of DP 
thymocytes can be observed that then lead to a disruptive development of SP 
T cells and naïve T cells. The declined number of T cells at the early age of 
Dicer deficient mice was already caused by the change of the 
microenvironment as numbers of cTECs increased which lead to a defective 
positive selection, mTEC numbers declined and the location of mTECs were 
predominantly located in the CMJ. In later stages the typical cortico-medullary 
organization got lost and TECs were not organized properly anymore. The 
property of the MHC II profile in mTEC has changed as the expression of 
immature mTECs has reduced and the proportion of mature mTECs has 
increased. Interestingly mature mTECs were not affected by the absence of 
mature microRNAs and still provided a range of self-antigens to ensure a 
proper negative selection process. Still T cells from Dicer-deficient mice are 
rather developing autoimmune diseases than control mice (Zuklys et al. 
2012). In another approach where Dgcr8 is deleted by Cre recombinase in 
TEC showed a very similar result with an impaired thymic structure with a loss 
of keratin-8 (K8) and keratin-5 (K5), which results to a disrupted separation of 
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the cTEC and mTEC compartment. Aire+ cells were reduced over time 
drastically and an increase of immature mTEC proliferation could be seen. 
Even though the numbers of cTECs and mTECs are aberrant and its thymic 
structure disorganised thymocyte development is still functioning and mice did 
not develop any spontaneous autoimmune diseases (Khan et al. 2014). Aire 
regulates the expression of microRNAs as the knockdown of Aire in 
mTEC2.10 cell line resulted in a changed miRNA expression level of 30 
miRNAs indicating that Aire controls the expression of certain miRNAs 
(Macedo et al. 2012). MiR-155, miR-150, miR-93 and miR-181b were found to 
play an important role in thymus involution. Deletion of miRNAs in the thymus 
has been reported to lead to a progressive loss of pGE, both Aire-dependent 
and Aire-independent genes, thus miRNAs and Aire share interdependence in 
pGE (Ucar et al. 2013). Numerous microRNAs have also been found in thymic 
epithelial tumours (TETs), a disease, which occurs normally rare, but is very 
heterogeneously and mostly benign but with infiltrating and metastasizing 
behaviour. In those significantly downregulated miRNAs found in this disease 
a prediction analyses could shown that they are all linked to important 
pathways such as Wnt, Notch, Transforming growth factor-β (TGF-β) and 
other prominent pathways (Ganci et al. 2014). Thus a tight regulation of 
miRNA expression is important for proper T cell maturation, maintenance of 
the thymus microenvironment and the proper development of TECs to provide 
an efficient selection of functional T lymphocytes. Failing to do so can cause 
autoimmunity and cancer. On the other hand stress can influence the 
expression of thymic miRNAs thus resulting in an impairment to provide an 
effective selection and maturation of T lymphocytes (Belkaya et al. 2011).  
1.5.1 Functional miRNAs in mTECs 
In the past few years’ three miRNAs have been discovered to play a crucial 
and functional role in mTEC development. MiR-29a was found to control 
thymic microenvironment and has a high expression in cTECs as well as in 
mTECs. Interestingly miR-29a deficient mice have a normal thymus 
architecture, normal development of TECs as well as proper T cell 
development but in the age of 4 weeks mice have a disruptive thymus 
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architecture which looks very similar to Dicer deficient mice with a profile 
indicating them undergoing thymic involution already in that early stage. It has 
been shown that miR-29 is essential for the maintenance of the thymic 
epithelial compartment and its hypersensitivity to pathogen-associated 
molecular pattern (PAMP) (Papadopoulou et al. 2012).  
Another miRNA is miR-205, which is found in mTECs with a high expression 
level compared to CD45+ cells and cTECs. The levels of miR-205 are 
comparable between Aire- and Aire+ mTECs, eventually slightly higher in 
immature mTECs. Mice with a deficiency of miR-205 did not show any 
differences in Aire expression, thymus architecture or influence the 
expression and maturation of mTECs. Nor did it show any reduction of T cell 
development compared to wild type or a reduced thymic cellularity. Additional 
to that no significant differences could be observed in the numbers of 
spleenocytes, Tregs and memory T cells comparing to controls thus indicating 
that miR-205 is not influencing the peripheral T cell homeostasis. 
Spontaneous autoimmunity could not be found in miR-205 deficient mice. 
There is a possibility that the relevant function of miR-205 in mTECs was not 
revealed eventually due to other members of the miR-200 family, which might 
compensate the loss of miR-205 in mTECs (Khan et al. 2015).  
Recently a new miRNA was found to play a role in mTEC by the interaction of 
TGF-β. MiR-181a-5p is lowering its expression levels in adult or aged mice 
compared to young mice. To investigate the role of miR-181a-5p in mTECs a 
cell line called murine thymic epithelial cell line 1 (MTEC1) was used and 
transfected with miR-181a-5p mimics or inhibitors. The cell viability was 
increased when MTEC1 was transfected with miR-181a-5p mimics, while 
inhibition of miR-181a-5p showed the opposite effect. MRNA levels of Cyclin1, 
Cyclin D3, Cyclin B1, Cyclin E1, Cdk4, Cdk6 and C-myc were all significantly 
increased when MTEC1 was upregulated and again the opposite expression 
levels of those genes were seen in miR-181a-5p inhibition. MiR-181a-5p was 
found to have a complementary sequence to Tgfbr1, a gene, which belongs to 
the TGF-β signalling pathway. When upregulating miR-181a-5p the mRNA 
expression level of Tgfbr1 went down as well as the protein level. Smad2 level 
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seem to be down as well on western blotting after the upregulation of miR-
181a-5p. Tgfbr1 expression increases during aging thus indicating a relation 
between miR-181a-5p, Tgfbr1 and thymic involution (Dongguan et al. 2016).  
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1.1 Objective of this study 
 
Previous studies have shown the involvement of particular microRNAs in 
terms of aging in mTECs, maintenance of thymic epithelial architecture and 
Aire expression on mTECs. However, the influence of microRNAs in the 
regulation of mTEC development from immature to mature mTECs has not 
been discovered yet. Thus, finding particular microRNAs playing a role to 
drive mTEC development will bring clarity how mTECs are regulated on the 
molecular level.  
 
The prime focus of this thesis was to identify microRNAs in different 
developmental stages and their mRNA targets. Three different experimental 
approaches have been used: 
 
1) Isolate murine mTEC subpopulations from different developmental 
stages by using surface markers such as MHC II, SCA-1 and CD24. 
Afterwards do microarray analysis to find specific microRNA and 
mRNA targets in those subpopulations.  
2) Use a mouse model to reconstruct a thymus, as the generation and 
development of mTEC can be followed in a dynamic manner.  
3) Generation of a miRNA-mRNA network by bioinformatics and prove the 
findings in a cell culture model to see their functional interaction with 
each other. 
 
The aim of the thesis is to understand how mTEC development is regulated to 
eventually use this knowledge to reconstruct a complete thymus or reprogram 
a thymus in terms of autoimmune diseases or cancer.  
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2 Materials and Methods 
2.1 Materials 
 
2.1.1 Chemicals 
 
Product        Company 
 
2.4G2        DKFZ (Bruno Kyewski lab) 
4',6-diamidino-2-phenylindole (DAPI)   Sigma 
6x DNA loading Dye      Fermentas 
100 bp DNA Ladder      Fermentas 
Acetone        Riedel-de Haën 
Acetic Acid       Sigma 
Agarose        Invitrogen 
B27         Invitrogen 
bFGF        Sigma 
ß-Mercaptoethanol       Invitrogen 
Bovine serum albumin (BSA), Fraction V  Sigma 
Cell proliferation dye eFluor 450   Affymetrix eBioscience 
Chloroform       Merck 
Collagen I, rat tail      Invitrogen 
Collagenase IV       Worthington 
Collagenase D       Roche 
CutSmart Buffer      New England Biolabs 
Dharmafect       Dharmacon 
Dispase Grade I (Neutral Protease)   Worthington 
DNase I        Roche 
dNTP mix 2mM       Thermo Scientific 
DMEM (+ Glucose, + L-Glutamine, + HEPES) Gibco 
Doxycyline Hyclate      Sigma 
EGF         Sigma 
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Ethylenediaminetetraacetic acid (EDTA)  Sigma  
Ethanol (absolute)      VWR 
Ethidium bromide      Roth 
Fetal calf serum (FCS)     Biochrom 
FuGENE HD       Promega 
Gold Taq polymerase     Life technologies 
GoTaq G2 Flexi DNA Polymerase (2500U) Promega 
Heparin        Sigma 
HEPES (solution)       Invitrogen 
Hydrocortisone       Sigma 
Insulin        Sigma 
Isofluran        Fluka 
Isopropanol       Sigma 
JM109 competent cells     Promega 
Linear polyacrylamide (LPA)    Thermofisher 
Lipofectamine 2000      Life technologies 
Magnesium Chloride      Sigma 
MEBM medium, pH 7.2-7.     Lonza 
NaCl, 0,9%       Braun 
Non-essential amino acids (NEA)   Gibco 
Novalgin, 50 mg/ml      Sanofi Aventis 
Nuclease-free water      Ambion 
Oligo(dT)        Life Technologies 
Opti-MEM mediu      Thermofisher    
Paracetamol       Ratiopharm 
PFA (Paraformaldehyde)     Merck 
Pmel        New England Biolabs 
1x Phosphate Buffered Saline (PBS)    Life technologies 
10x Phosphate Buffered Saline (PBS)   Biochrom 
Penicillin/Streptomycin     PAA 
Prolong Gold Antifade Reagent with DAPI   Life Technologies 
Propidium Iodide       Sigma 
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Proteinase K recombinant PCR Grade  Roche 
RNAlater        Life Technologies 
RPMI 1640 with L-Glutamine    Gibco 
SiGlo Green       Thermo Scientific 
Sucrose        Sigma 
SOC medium       Thermofisher 
Sodium Acetate      Sigma 
T4 DNA ligase       New England Biolabs 
T4 DNA ligation reaction buffer    New England Biolabs 
Tris/Acetate       Sigma 
Triton-X-100       Merck 
TRIzol        Invitrogen 
Trypan Blue       Merck 
Trypsin        Gibco 
ViaFect        Promega 
Xbal         New England Biolabs 
       
2.1.2 Dispensable materials and commercial kits 
 
Product        Company 
 
AutoClip 9mm, wound clips    BD 
Auto MACS columns      Milteny Biotech 
Cell culture dishes (6 wells, 24 well)   TPP 
Cell strainer cap tubes (5 ml)    BD 
Cell strainer (40, 70 100 μm)    BD 
Cell-Strainer-Cap Tubes (5ml)    BD 
Cell Strainer (40, 70, 100 μm)    BD 
Centrifuge Tubes (15 and 50 ml)   TPP 
DNeasy Blood & Tissue Kit    Qiagen 
Dual-luciferase reporter assay    Promega 
Falcon Tubes (15 and 50 ml)    BD 
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Flat-bottom plates (6, 12, 24, 96 well)  TPP 
Filter papers Ø 55mm     Macherey-Nagel 
Filter tips (10, 20, 100, 200, 1000 μl)   Starlab 
First-Strand cDNA Synthesis Super Script II RT Invitrogen 
Foliodrape       Hartmann 
Glasses with ventilation holes     DKFZ 
High Pure RNA isolation kit    Roche 
High Pure miRNA isolation kit    Roche 
Latex surgical gloves, powdered    Ansell medical 
Microlance (different sizes)     BD 
Miniprep        QIAGEN 
mRNA microarray mouse     Agilent 
miRNA microarray mouse      Agilent 
Neubauer Improved C-Chip DHC-N01  Digital Bio 
Nucleopore filter, 0.8 μm      Whatman 
Ophthalmic ointment Bepanthen    Bayer 
OptiPlate 96 white       Perkin Elmer 
Pasteur pipette       Brand GmbH 
PmirGLO Dual-luciferase miRNA target   Promega 
expression vector 
Parafilm        Pechiney Plastic Packaging 
PCR reaction tubes (200 μl)    Biozym 
Pipet tips without Filter (10, 200, 1000 μl)   Starlab 
Polypropylene round bottom tubes (5 ml)   BD 
Power SYBR Green PCR Master Mix   Applied Biosystems 
RNaseZap       Ambion 
Round bottom plates (96 well)    TPP 
Round bottom screw-cap tubes    Nunc 
Safe-lock tubes (0,5, 1,5, 2 ml)    Eppendorf 
Sterile filters        Millipore and Sartorius 
Sponge, 2 x 2 cm      Baumarkt Obi 
Suggi, mounted swabs     Kettenbach 
2	Materials	and	Methods	
28	
Surgical suture material, PGA Resorba  Resorba 
SuperScript II RT      Invitrogen 
Syringes (1, 5, 10, 20, 50 ml)    Terumo 
TaqMan microRNA Reverse Transcription kit Applied Biosystems 
Taqman Universal PCR Master Mix UNG  Applied Biosystems 
TRIzol        Invitrogen 
Ultra low attachment plates (6, 96 well)  Corning 
Vacuum filtration – Filtermax    TPP 
VIROMER Green       Lipocalyx 
 
2.1.3 Media, buffers and commercial solutions 
 
Trypan Blue 
  Trypan Blue     0.2% 
  NaCl  
  pH 7.0      150 mM 
 
RTOC and cell culture medium 
  FCS       10% 
  Pen/Strep      50 μg /ml 
  HEPES      10 mM 
  β-Mercaptoethanol    50 μM 
  Non-essential amino acids  1x 
  B27       1x 
  βFGF      20 ng/ml 
  EGF       20 ng/ml 
  Heparin      4 μg/ml 
  Hydrocortisone     0.5 μg/ml 
  Insulin      5 μg/ml 
  in DMEM with L-Glutamine 
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Collagenase solution 
  Collagenenase IV    0.25 mg/ml 
  DNase I      25 μg/ml 
  HEPES      10 mM 
  FCS       3% (v/v) 
  in RPMI 1640 medium pH 7.2 
 
Collagenase/ Dispase solution 
  Collagenenase IV    0.2 mg/ml 
  Dispase Grade I    0.2 mg/ml 
  DNase I      25 μg/ml 
  HEPES      10 mM 
  FCS       3% (v/v) 
  in RPMI 1640 medium pH 7.2 
 
FACS buffer 
  FCS       3% 
  in PBS pH 7.2-7.4  
 
GM buffer 
  BSA       0.5% (v/v) 
  EDTA      5 mM 
  in PBS pH 7.2-7.4 
 
RBC lysis buffer 
  H2O       900 ml 
  NH4Cl      8.26 g 
  KHCO3      1 g 
  EDTA (0.1 mM final)    0.037 g 
  Make up to 1l pH 7.4 
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RPMI medium 
  FCS       3% 
  Pen/Strep      50 μg/ml 
  HEPES      10 mM 
  in RPMI 1640 pH 7.2 
 
Trypsin solution for embryonic thymus digest 
  Trypsin      0.25% 
  EDTA      0.2% 
  in PBS pH 7.2-7.4 
 
1.2% Agarose gel 
  Agarose       1.2 g 
  1x TAE buffer     100 ml 
  Ethidium bromide    5 ml 
 
Tris-acetate-EDTA (TAE) buffer 
  Tris/Acetate     40 mM 
  EDTA      1 mM 
  in distilled water pH 7.5-8.0 
 
2.1.4 Magnetic beads and Microbeads used for MACS purification 
 
Product       Company 
 
Anti-CD45 microbeads    Miltenyi Biotech 
Anti-CD90.2 microbeads    Miltenyi Biotech 
OneComp eBeads     affymetrix eBioscience 
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2.1.5 Antibodies 
 
Product  Species Isotype Conjugate  Clone Company 
 
CD11c  rat  IgG  Biotin  HL3  BD 
CD11b  rat  IgG  Biotin  M1/70 BD 
CD19  rat  IgG  Biotin  ID3  BD 
CD24  rat  IgG  PE-Cy5, PB M1/69 eBioscience 
CD24  rat  IgG  FITC   M1/69 Biolegend 
CD25  rat   IgG  Bril. Violet421 PC61 Biolegend 
CD3   rat  IgG  Pe-Cy5  17A2 BD 
CD4   rat  IgG  PE, FITC  H129.19  BD,BioLegend 
CD44  rat  IgG  Alexa647  IM7  BioLegend 
CD45  rat  IgG  PerCP  30-F11 BD 
CD8   rat  IgG  PE, PE-Cy5 53-6.7 BD 
CD8   rat  IgG  FITC   53-6.7 BD 
CD80  ham  IgG  PE   16-10A1 BD 
CD119  mouse IgG  Biotin  2E2  BD 
EpCAM  rat  IgG  Alexa 647  G8.8  DKFZ 
I-A/I-E  rat  IgG  PE, FITC  M5  BD 
Ly51   rat  IgG  FITC, PE  6C3  BD 
Ly-6A/E  rat  IgG  PE-Cy7  D7  BD 
MHCII  rat  IgG  FITC, Biotin 2G9  BD 
Sca-1  rat  IgG  PE-Cy7  D7  BD 
Streptavidin -  -  APC-Cy7  -  BD 
Ter119  rat  IgG  Biotin  Ter119 Invitrogen 
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2.1.6 MiRNA primers, siRNA, antagomiRs and mimics 
 
Product    Target    Company 
 
Hsa-miR-125b   miR-125b    Life technologies  
Hsa-miR-203   miR-203    Life technologies 
Hsa-miR-29a   miR-29a    Life technologies 
Hsa-miR-34a   miR-34a    Life technologies 
Hsa-miR-92   miR-92    Life technologies 
Mmu-miR-1a-1*  miR-1a-1    Life technologies 
Mmu-miR-125a-5p  miR-125a-5p   Life technologies 
Mmu-miR-200c   miR-200c    Life technologies 
Mmu-miR-203*   miR-203    Life technologies 
Mmu-miR-205   miR-205    Life technologies 
Mmu-miR-324-5p  miR-324-5p   Life technologies 
Mmu-miR-34a-3p  miR-34a-3p   Life technologies 
Mmu-miR-34b-3p  miR-34b-3p   Life technologies 
Hsa-miR-34b-5p  miR-34b-5p   Life technologies 
Mmu-miR-494   miR-494    Life technologies 
Mmu-miR-709   miR-709    Life technologies 
Mmu-miR-761   miR-761    Life technologies 
Mmu-miR-877*   miR-877    Life technologies 
Mmu-miR-let-7c-1*  let-7c-1    Life technologies  
RNU48    RNU48    Life technologies 
U6 snRNA   U6     Life technologies 
mirVana inhibitor miR-125 miR-125a-3p   Life technologies 
mirVana inhibitor miR-125 miR-125a-5p   Life technologies 
mirVana inhibitor miR-125 miR-125b-1-3p   Life technologies 
mirVana inhibitor miR-125 miR-125b-5p   Life technologies 
mirVana inhibitor miR-200 miR-200c-3p   Life technologies 
mirVana inhibitor miR-203 miR-203a    Life technologies 
mirVana inhibitor miR-205 miR-205-5p   Life technologies 
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mirVana inhibitor miR-29 miR-29a-3p   Life technologies 
mirVana inhibitor miR-34a miR-34a-5p   Life technologies 
mirVana inhibitor miR-34 miR-34b-3p   Life technologies 
mirVana inhibitor miR-34c miR-34c-5p   Life technologies 
mirVana inhibitor miR-494 miR-494-3p   Life technologies 
mirVana inhibitor miR-709 miR-709    Life technologies 
mirVana inhibitor miR-761 miR-761    Life technologies 
mirVana inhibitor miR-877 miR-877-3p   Life technologies 
mirVana inhibitor miR-92 miR-92a-3p   Life technologies 
mirVana inhibitor let-7c let-7c    Life technologies 
mirVana inhibitor neg. ctrl scramble miRNA control Life technologies 
mirVana mimic miR-125 miR-125a-3p   Life technologies 
mirVana mimic miR-125 miR-125a-5p   Life technologies 
mirVana mimic miR-125 miR-125b-1-3p   Life technologies 
mirVana mimic miR-125 miR-125b-5p   Life technologies 
mirVana mimic miR-200c miR-200c-3p   Life technologies 
mirVana mimic miR-203 miR-203-3p   Life technologies 
mirVana mimic miR-205 miR-205-5p   Life technologies 
mirVana mimic miR-29 miR-29a-3p   Life technologies 
mirVana mimic miR-34a miR-34a-5p   Life technologies 
mirVana mimic miR-34b miR-34b-3p   Life technologies 
mirVana mimic miR-494 miR-494-3p   Life technologies 
mirVana mimic miR-709 miR-709    Life technologies 
mirVana mimic miR-761 miR-761    Life technologies 
mirVana mimic miR-877 miR-877-3p   Life technologies 
mirVana mimic miR-92a miR-92a-3p   Life technologies  
mirVana mimic neg. ctrl scramble miRNA control Life technologies 
silencer siRNA Abcb1b Abcb1b    Ambion 
silencer siRNA Acsbg2 Acsbg2    Ambion 
silencer siRNA Apln  Apln     Ambion   
silencer siRNA Arid3b Arid3b    Ambion 
silencer siRNA Bak1  Bak1    Ambion 
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silencer siRNA Bcl6  Bcl6     Ambion 
silencer siRNA Btg2  Btg2     Ambion 
silencer siRNA Col4a4 Col4a4    Ambion 
silencer siRNA Dcx  Dcx     Ambion 
silencer siRNA Dhcr24 Dhcr24    Ambion 
silencer siRNA Dusp7 Dusp7    Ambion 
silencer siRNA Egr2  Egr2     Ambion 
silencer siRNA Fam83e Fam83e    Ambion 
silencer siRNA Fbxo45 Fbxo45    Ambion 
silencer siRNA Fgf23 Fgf23    Ambion    
silencer siRNA Fli1  Fli1     Ambion 
silencer siRNA Foxp1 Foxp1    Ambion 
silencer siRNA Gapdh  Gapdh    Ambion 
silencer siRNA Grtp1  Grtp1    Ambion 
silencer siRNA Jun  Jun     Ambion 
silencer siRNA Mapk14 Mapk14    Ambion 
silencer siRNA neg. ctrl scramble mRNA control Ambion 
silencer siRNA Psmb11 Psmb11    Ambion 
silencer siRNA Rab11b Rab11b    Ambion 
silencer siRNA Rps15a Rps15a    Ambion 
silencer siRNA Sall4  Sall4     Ambion 
silencer siRNA Sgms2f Sgms2f    Ambion 
silencer siRNA Sirt1  Sirt1     Ambion 
silencer siRNA Sirt3  Sirt3     Ambion 
silencer siRNA Slc22a17 Slc22a17    Ambion 
silencer siRNA Tbx5  Tbx5     Ambion 
silencer siRNA Tirap  Tirap    Ambion 
silencer siRNA Tnf  Tnf     Ambion 
silencer siRNA Trp63 Trp63    Ambion 
silencer siRNA Ubac1 Ubac1    Ambion 
silencer siRNA Zeb1  Zeb1    Ambion 
silencer siRNA Zfp113 Zfp113    Ambion 
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silencer siRNA Zfp300 Zfp300    Ambion 
 
2.1.7 Oligonucleotides for vector cloning 
 
Product    Sequence      Company 
 
Bak1-miR-125b-5p 
5’AAACTAGCGGCCGCTAGTCGGCGGCTGGACTCTCAGGGATTCT3’ 
3’TTTGATCGCCGGCGATCAGCCGCCGACCTGAGAGTCCCTAAGAGATC5’ 
Bak1-miR-125b-5p mut  
5’AAACTAGCGGCCGCTAGTCGGCGGCTGGACTAGGAGGGATTCT3’ 
3’TTTGATCGCCGGCGATCAGCCGCCGACCTGATCCTCCCTAAGAGATC5’ 
Mapk14-miR-125b-5p  
5’AAACTAGCGGCCGCTAGTTAAAGATGAATCCTCAGGGGTGAAGT3’ 
3’TTTGATCGCCGGCGATCAATTTCTACTTAGGAGTCCCCACTTCAGATC5’ 
Mapk14-miR-125b-5p mut  
5’AAACTAGCGGCCGCTAGTTAAAGATGAATCCTAGCGGGTGAAGT3’ 
3’TTTGATCGCCGGCGATCAATTTCTACTTAGGATCGCCCACTTCAGATC5’ 
Fam83e-miR-125a-3p  
5’AAACTAGCGGCCGCTAGTTCAGCTGCCTCACCATGTACTATT3’ 
3’TTTGATCGCCGGCGATCAAGTCGACGGAGTGGTACATGATAAGATC5’ 
Fam83e-miR-125a-3p mut  
5’AAACTAGCGGCCGCTAGTTCAGCTGCCTCGAAATGTACTATT3’ 
3’TTTGATCGCCGGCGATCAAGTCGACGGAGCTTTACATGATAAAGATC5’ 
Foxp1-miR-34a-5p   
5’AAACTAGCGGCCGCTAGTGCATGTTGATACCACTGCCTT3’ 
3’TTTGATCGCCGGCGATCACGTACAACTATGGTGACGGAAGATC5’ 
Foxp1-miR-34a-5p mut  
5’AAACTAGCGGCCGCTAGTGCATGTTGATACCAGGACCTT3’ 
3’TTTGATCGCCGGCGATCACGTACAACTATGGTCCTGGAAGATC5’ 
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2.1.8 PCR primers 
 
Product   Sequence       Company 
 
Aire fwd   ATAGCATCCTGGACGGCTTC   Eurofins 
Aire rev   GCTCCTCCAGTGCTTTTCTC    Eurofins 
Bak1 fwd   TACATCGCCAGATGGATCGC   Eurofins 
Bak1 rev   TCCCCTGTCATAGTGGCTGA   Eurofins 
Casein b fwd  TCTGTCTAAGAGGATTTCCAGGTT  Eurofins 
Casein b rev  CATTTCCAGTTTCAGTCAGTTCA   Eurofins 
CD80 fwd   TCAGAAGAAATGAGGCAAGCAG   Eurofins 
CD80 rev   AAGGAAGACGGTCTGTTCAGCT   Eurofins 
Dicer fwd   CCATTTGCTGGAGTCACTCTG  Eurofins 
Dicer rev   TAAATCTGGCAAGcGAGACG   Eurofins 
EpCAM fwd  CTTGCAGACTGCGCTTCA    Eurofins 
EpCAM rev  CCCCCTTCACA TCTTTTTCA    Eurofins 
Fam83e fwd  AGAGCGGCAATTCCACTTCG   Eurofins 
Fam83e rev  TGCCAGAATGAAGGCCAAGG  Eurofins 
FoxN1 fwd  CTCTTCCCAAAGCCCATCTA    Eurofins 
FoxN1 rev   AGGCTTCCGGTCTTACTGTTC   Eurofins 
FoxN1 Cre fwd  CATTGTAGCTGGCTTTCTTCGAG  Eurofins 
FoxN1 Cre rev  GAAGCATGTTTAGCTGGCCC   Eurofins  
Foxp1 fwd   CAGCCACCCTCTCTATGGAC   Eurofins 
Foxp1 rev   AGCGCATGCTCACTGTTG   Eurofins 
Gad1 fwd   GGTTCGCACAGGTCACCC    Eurofins 
Gad1 rev   GCCATTCACCAGCTAAACCAA  Eurofins 
Gapdh fwd  GGGTTCCTATAAATACGGACTGC   Eurofins 
Gapdh rev  CCATTTTGTCTACGGGACGA    Eurofins 
Mapk14 fwd  CCCAGCAACCTAGCTGTG   Eurofins 
Mapk14 rev  GCTCGGTACCACCTGGTAG   Eurofins 
Meis1 fwd   GACGCTTTAAAGAGAGATAAAGATGC Eurofins 
Meis rev   CATTTCTCAAAATCAGTGCTAAGA  Eurofins 
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MHC II fwd  TGCCTTAGAGATGGCTCTGC   Eurofins 
MHC II rev  CCATGAACTGGTACACGAAATG   Eurofins 
Pdpn fwd   GTTTGGTTCTGGGACTCTGC    Eurofins 
Pdpn rev   TCCAGTAGCACCTGTGGTTG   Eurofins 
Sirt1 fwd   TGGAAGGAAAGCAATTTTGGT  Eurofins 
Sirt1 rev   CTGAGTTACCTTAGCTTGGC   Eurofins 
Trp63 fwd   TTCCGTGAGCCAGCTTATCA   Eurofins 
Trp63 rev   GTCTCCAGCCATTGGCATGT   Eurofin 
 
2.1.9 Equipment  
 
Product       Company 
 
Aluminium Plate     DKFZ 
AutoMACS Pro Separator    Miltenyi Biotech 
Axio Imager.Z1 Microscope   Carl Zeiss 
BD FACSAria Cell Sorter    BD 
BD FACSCantoTM Flow Cytometer   BD 
Bone cutters      Fine Science Tools 
Bone Scraper      Fine Science Tools 
Bulldog Type Serrefine straight, 35mm Fine Science Tools 
Cell Observer      Zeiss 
Centrifuge Rotanta 460 R     Hettich 
Confocal microscope     Olympus 
Cryostat (CM3050 S)    Leica 
Curved forceps, 7-Inox-H    Fine Science Tools 
Fine forceps, 5-Inox-H    Fine Science Tools 
Forceps       Fine Science Tools 
Gel electrophoresis Camera    AGS 
Heating Block      Eppendorf 
Hemostat, straight, 14 cm    Fine Science Tools 
Ice machine AF80     Scotsman 
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Incubator HeraCall 240i    Thermo Scientific 
Incubator Memmert     Memmert 
Isoflurane evaporator     DKFZ 
Magnetic Bar (MR200)     Heidolph 
Micro pipets (2-1000μl)     Gilson 
Micro scale CP224S      Sartorius 
Microwave      Siemens 
Millipore Milli-Q Plus     Millipore 
Multichannel pipet (8,12 channels)  Eppendorf 
Nano-Drop® 100 photometer    Thermo Scientific 
Neubauer-Counting chamber    Brand 
PCR-Machine (PTC100TM)   MC Research 
Reflex 9 Wound Clip Applicator   Fine Science Tools 
Reflex Wound Clip Remover   Fine Science Tools 
Scissors       Fine Science Tools 
Sterile Hood Hera Sate    Heraeus 
Stereo dissecting microscope Stemi DV4 Zeiss 
Table Centrifuge (Biofuge)    Heraeus 
Tabletop microscope Axiostar Plus   Zeiss 
Thermo mats      Dehner 
Vortexer       Scientific industries 
Water Bath       Braun 
 
2.1.10 Cell lines  
 
HEK293T cells were kindly provided by Olga Ucar (DKFZ).  
 
2	Materials	and	Methods	
39	
 
 
 
 
2.1.11 Softwares and homepages  
 
Product       Provider / Company 
 
Adobe Acrobat X Pro     San Jose 
AxioVision LE (4.4)      Zeiss 
EndNote (X4)      Adept Scientific 
FACS Diva software (6.0)     BD 
FlowJo (8.8.7)      Tree Star 
GraphPad Prism (6.0)     GraphPad 
Inkscape       Inkscape 
IOS        Apple 
microRNA sequence     www.microRNA.org 
microRNA-mRNA interactions   TargetScan 
Microsoft Office 2010     Microsoft 
SoftMax Pro      Molecular Devices 
Spectra Max M5 plate reader   Molecular Devices 
2.1.12 Mouse strains  
 
C57BL/6 mice were purchased and/or time mated from the animal facility at 
German Cancer Research Center (DKFZ) as well as from Charles River 
(Germany). The time point where a female mouse was declared as pregnant 
“day 0” was based on the vaginal plug detection.  
SCID mice (CB17/lcr-Prkdcscid/lcrlcoCrl), nude mice, NMRI mice, balb/c mice 
were purchased at Charles River (Germany and USA). ROSA26-tmTomato-
tmGFP mice, which express constantly tomato fluorescent protein, were 
kindly provided by Roger Sandhoff (DKFZ).  
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Dicer KO mice are mice originally Foxn1cre mice which were inter-crossed with 
Dicerflox/flox mice to produce mice with thymic epithelial cell-specific excision of 
Dicer on the C57BL/6 background. Those mice were provided from Olga Ucar 
(DKFZ).  
All mice were kept under specific pathogen-free conditions in the animal 
facility at the DKFZ.  
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2.2 Methods 
2.2.1 Isolation of murine tail DNA 
The isolation of genomic DNA from murine tails was performed with the 
DNeasy Blood & Tissue Kit. A short piece of tail in the length between 2-5mm 
is needed for the DNA isolation. DNeasy Blood & Tissue Kit from Qiagen was 
used and the instructions were followed according to the manufacturer’s 
manual. The final sample was eluted with 50 ml of buffer and the 
concentration was determined by nano drop. Afterwards the DNA is ready for 
PCR or it can be stored in the freezer (-80 degrees) for long-term storage.  
 
2.2.2 Isolation of RNA from sorted cells or tissue 
For the isolation of total cellular RNA two methods were used either with the 
High Pure RNA isolation kit from Roche and the instruction was followed by 
the manufacturer’s protocol and the other method was an isolation of RNA 
with TRIzol. If using tissues, the tissue has to be homogenized in 1 ml of 
TRIzol per 50-100 mg of tissue. Let sample rest for 5 minutes at room 
temperature and spin down the tube and transfer the supernatant to a fresh 
eppendorf tube. If using cells in suspension, spin down cells for 5 minutes at 
300 x g and remove the media and re-suspend the cells in ice-cold PBS and 
repeat that step but instead of re-suspending cells in PBS use 1ml TRIzol. 
Use a P100 and pipet up and down for at least 30 times to ensure the 
disruption of the cell walls. Now add 200 ml of chloroform per 1 ml of TRIzol 
reagent and vortex the sample vigorously for 15 seconds and let the sample 
incubate for 2-3 minutes at room temperature. Then centrifuge the sample at 
12,000 x g for 15 minutes at 4 degrees. After the centrifugation the mixture 
has separated into a lower red phenol-chloroform phase, an intermediate 
phase and an upper colourless aqueous phase. The RNA is only in the upper 
phase and can be transferred carefully with a plastic Pasteur pipette to a fresh 
tube, be aware not disturbing the other phases. Measure the volume, which 
has been transferred to the new tube. To precipitate the RNA, the protocol for 
RNA precipitation has been used.  
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2.2.3 Isolation of miRNA 
The isolation of miRNA was done with the High Pure miRNA isolation kit from 
Roche. The instruction was followed by the two-column protocol to isolate 
purified small RNAs. The miRNA concentration was measured by nana drop.  
 
2.2.4 RNA precipitation 
RNA precipitation can to reduce the volume size of the RNA sample. Place 50 
ml of RNA sample in an eppendorf tube and add 5 ml of 3M Sodium Acetate 
and 1 ml linear polyacrylamide (LPA) to the sample. Add additional 125 ml 
ice-cold 100% ethanol and invert the sample twice. Precipitate for 30 min at -
80 degrees or at -20 degrees overnight. Then spin the eppendorf tube at 
13,000 x g for 30 minutes at 4 degrees. Afterwards decant the supernatant 
and pipet the pellet dry. Next add 500 ml of 70% ice-cold ethanol, vortex, spin 
down at 13,000 x g for 5 minutes at 4 degrees and discard the supernatant. 
Repeat this step. Pulse-spin the tube at maximum speed to collect all residual 
ethanol and let the pellet air dry for 5-10 minutes. Finally re-suspend the pellet 
with 10 ml RNase-free water.  
 
2.2.5 MiRNA Reverse Transcription 
The conversion of RNA to cDNA for miRNA RT-qPCR has been done with the 
TaqMan microRNA reverse transcription kit from Applied Biosystems. The 
protocol from the manufacturer has been used. The cDNA has been stored in 
-80 degrees or has been processed immediately for RT-qPCR. 
 
2.2.6 cDNA Synthesis 
The conversion of RNA to cDNA for RT-qPCR has been performed based on 
the SuperScript II reverse transcription protocol from Invitrogen.  
 
2.2.7 Genotyping PCR 
Prepare the master mix on ice by adding the following 2 ml of 10x buffer, 2 ml 
of MgCl2 25 mM, 4 ml of dNTP’s 2 mM, 0.1 ml of forward primer 100 pM, 0.1 
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ml of reverse primer 100 pM, 0.2 ml of Gold Taq Polymerase, 14 ml of water 
and 2 ml of genomic DNA.  
The following PCR settings has been used: 
• Activation of polymerase for 9 minutes at 94 degrees 
• Denaturation for 1 minute at 94 degrees 
• Annealing for 1 minute at 60 degrees          30 cycles 
• Elongation for 1.5 minutes at 72 degrees 
• Elongation for 9 minutes at 72 degrees 
 
2.2.8 Thymus dissection and medullary epithelial cell preparation 
Sacrifice mice with CO2 and remove their thymi by ripping up the rib cage 
upwards. Place thymi into the petri dish that is filled with RPMI medium and 
place the dish on ice. Clean the thymi by removing blood vessels and 
connective tissues and transfer those clean thymi into a fresh petri dish filled 
with fresh RPMI medium Then chop those thymi in small pieces and transfer 
them with a Pasteur pipette into a round-bottom tube (in each tube place up to 
6 adult thymi) and add a small stir bar into the tube. Use for each thymus 1 ml 
pre-warmed collagenase solution. Place the round-bottom tube into a water 
bath at 30 degrees for 15 minutes and turn the magnetic stirrer on. After 7 
minutes of incubation re-suspend the collagenase thymi solution with a 
broken pipette. After 15 minutes transfer the supernatant to a falcon tube 
(placed on ice) and add 5 ml of RPMI medium to stop the enzymatic reaction. 
Add new collagenase solution to the round-bottom tube and stir for another 15 
minutes, while re-suspending the solution with a broken pipette after 7 
minutes to avoid clotting of the tissues. After 15 minutes transfer the 
supernatant to the same falcon tube. That tube consists mostly of T cells and 
no medullary thymic epithelial cells and can be used for T-cell analysis or 
discarded. Now add 1 ml collagenase/dispase solution per thymus to the 
round-bottom tube and increase the water bath temperature to 37 degrees 
and stir now for 25 minutes, while after 15 minutes of incubation re-suspend 
the solution with a pipette. After the 25 minutes transfer the supernatant to a 
fresh falcon tube filled with fresh RMPI medium (5 ml). Repeat the digestion 
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with collagenase/dispase solution for another 4 times, where each time the 
supernatant is collected after 25 minutes of incubation. Now spin down all 
falcon tubes for 1,400 rpm for 5 minutes at 4 degrees. Now re-suspend with 5 
ml RPMI medium all falcon tubes, which have been used to collect all 
supernatant of the collagenase/dispase fraction. Then let the solution to go 
through a 70 mm pre-wet cell strainer and wash the cell strainer with another 
5 ml RPMI medium and mix it well before counting the cells. After counting 
add 10 ml of GM buffer to the solution and centrifuge at 1,200 rpm for 5 
minutes at 4 degrees. Discard the supernatant and add 1 ml GM buffer for 
each 1x108 cells. Then add 40 ml of microbeads per 1 ml GM solution (1/25 
volume of MACS beads) and incubate the solution for 30 minutes at 8 
degrees in the dark, while stirring the tube after 15 minutes. Meanwhile 
prepare the MACS stand on ice and pre-wet the MACS separation columns 
with 3 ml GM buffer. Wait until the column is dry again before starting with the 
depletion; when the column is dry place a fresh falcon tube filled with 1ml 
RPMI medium under the column to collect the depleted cells. After 30 minutes 
of incubation wash the falcon tube with the same volume with GM buffer, 
vortex shortly, and centrifuge with 1,400 rpm for another 5 minutes at 4 
degrees. Discard the supernatant and re-suspend the pellet with 1 ml GM 
buffer for 1x108 cells. Apply for each column up to 2x108 cells, wait until the 
solution went through the column and then wash the column twice with 3 ml 
GM buffer. Centrifuge the flow-through at 1,200 rpm for 5 minutes at 4 
degrees, re-suspend the pellet with RPMI medium, filter through a pre-wet cell 
strainer and count the cells again. Place the cell solution in ice for further 
analysis.  
 
2.2.9 Thymus dissection and isolation of embryonic medullary 
thymic epithelial cells 
The removal of fetal thymi in the age of E14.5 was under microscope. Blood 
vessels were removed and transferred to an eppendorf tube filled with cold 
PBS. The thymi were washed four times and then transferred to a tube with 
1.5 ml pre-warmed collagenase/dispase solution, up to 10 thymi per tube. 
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Tube was placed in a water bath with 37 degrees for 5 minutes. After 5 
minutes a P200 pipette was used to enforce the digest mechanically by 
pipetting up and down for at least 30 times. This step was repeated twice. 
Alternatively this digestion can be done with Trypsin-EDTA but instead of 15 
minutes, the time will be reduced to 8 minutes. Only 600 ml of Trypsin-EDTA 
is used and after 5 minutes, pipette with a P200 at least 30 times up and 
down to enforce the digest. Then place the tube back to the water bath for 
another 1 minute and repeat the digest enforcement with the P100 pipette. If 
the digest is still not complete, repeat the final step again. Trypsin digest is 
harsher compared to the collagenase/dispase solution. After all thymi were 
digested, RPMI medium was added to the tube to stop the enzymatic reaction. 
The cell suspension was then transferred to a FACS tube with a pre-wet filter 
on top of it. The eppendorf tube was washed twice, each time going through 
the same filter. FACS tubs were then centrifuged at 1,400 rpm for 5 minutes at 
4 degrees. Remove the supernatant and re-suspend the pellet with RTOC/cell 
culture medium and placed in ice.  
 
2.2.10 Re-aggregate Thymus Organ Culture (RTOC) 
The re-aggregate thymus organ culture is a method to culture mTECs in a 3D 
structure. Put a 6 well plate under the sterile hood, place in each well a sterile 
sponge (in the thickness of around 5 mm) and then use a sterile syringe 
plunger and press on the sponge so it can soak up the medium, avoid any 
bubbles during that procedure. Place on top of the sponge a Whatman 
membrane. Place the well plate to the incubator. Meanwhile count the cells, 
which has been harvest from the E14.5 embryos and distribute 0.5x106 cells 
in each eppendorf tube. Centrifuge all eppendorf tubes and remove the 
supernatant. Take out the well plate to a sterile place. Do a quick spin to 
remove the residual supernatant in the eppendorf tubes. Transfer with a P10 
pipette the cell pellet onto the membrane. Place the well plate back to the 
incubator (37 degrees, 10% Co2). The re-aggregation will take place in the 
next hours. A RTOC can be kept up to 7 days by replacing the medium in 
each well every 3 days.  
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2.2.11 FACS staining of mTECs 
After the enrichment of TECs cells were re-suspended in RPMI medium. 
Centrifuge the cell suspension at 1,400rpm for 5 minutes at 4 degrees. 
Remove the supernatant and block for 15 minutes with anti-Fc-receptor 
solution (2.4G2), 1 ml of 2.4G2/ 1x108 cells. Place the tube in the dark at 4 
degrees. After the incubation time, wash the cells and stain the cells with the 
following antibody cocktails for 15 minutes for the primary antibody, wash with 
FACS buffer and incubate for another 15 minutes for the secondary antibody. 
Then wash again, centrifuge and then re-suspend in FACS buffer and place 
the tube on ice in the dark.  
 
For mTEC detection following antibodies were used: 
 
Antibody    Marker 
CD24    T-cell and B-cell differentiation 
CD45    Non-hematopoietic cells 
CD80    mTECs 
DAPI     dead cell exclusion 
EpCAM    mTECs and cTECs express EpCAM 
Ly51     cTECs   
MHC II    mTECs 
Sca-1       hematopoietic cells  
Ter119     Erythroid cells 
 
2.2.12 Bone marrow transplantation 
The bone marrow was isolated from 6 weeks old balb/c mice. Balb/c were the 
background from the SCID mice, which were transplanted with the isolated 
bone marrow. The bone marrow was removed; erythrocytes and CD90.2 cells 
were depleted. SCID mice were 5 weeks old when they arrived the animal 
facility and were left for 1 week before transplantation. 2x107 cells were 
injected intravenously (i.v.) per mouse when SCID mice were in the age of 6 
weeks. All SCID mice were injected at the same time. For each time point 24 
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SCID mice have been injected with bone marrow and another 24 injected with 
PBS to serve as a control.   
 
2.2.13 Transient transfections with freshly isolated cells 
After freshly isolated mTECs have been sorted for CD80/MHC II low, cells 
were transferred to a falcon tube filled with RTOC medium and on ice. Then 
cells have been centrifuged and cells were counted. We used for each 
transfection 150.000 cells. Cells were transferred to a 24 well plate and 
placed to the incubator. Meanwhile miRNA mimics, antagomiRs or siRNAs 
have been diluted down to 11 mM using Buffer Green with a final volume of 
15 ml. Place 3 ml of Viromer Green on the wall of an eppendorf tube and add 
immediately 270 ml of Buffer Green by flushing down the 3 ml off the wall and 
vortex shortly for 3-5 seconds. Then add 125 ml of the mixed solution to the 
15 ml of miRNA mimic, antagomiR or siRNA and mix it well and incubate for 
15 minutes in the dark at room temperature. After the incubation time add 
each transfection solution to the cells, by dropping slowly to the cell 
suspension and shake well. Cells were harvest and washed after 14-16 hours 
of incubation and were put into a RTOC system. After 4 days cells were 
analysed.  
 
2.2.14 Vector generation, Transformation, Co-transfection 
The vector used for the luciferase assay was the pmirGLO vector. The 
oligonucleotides were designed to have two restriction enzyme sites, one 
Pmel and the other one Xbal, thus to ensure the oligonucleotide to be placed 
into the right 5’ to 3’ direction. First vector is digested with Pmel and Xbal to 
generate the overhangs. Add Plasmid (in 1 mg/ ml concentration), CutSmart 
Buffer, Pmel, Xbal, BSA and sterile water to a clean tube and make it up to 20 
ml. Incubate digestion for 1 hour at 37 degrees. Stop digestion at 65 degrees 
for 15 minutes. Check plasmid length with gel electrophoresis. 
Oligonucleotides were diluted down to 1 mg/ ml, oligonucleotides and oligo 
annealing buffer were mixed together and heated it up to 90 degrees for 3 
minutes and then transferred to a 37 degrees water bath for 15 minutes. Then 
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mix 4 ng of annealed oligonucleotides with 50 ng of linearized vector, as well 
as ligation reaction buffer and T4 DNA ligase and mix it thoroughly. Incubate 
for 30 minutes at room temperature. Afterwards place it on ice. Preheat the 
SOC medium to 42 degrees and meanwhile chill sterile polypropylene culture 
tubes on ice. Thaw the JM109 competent cells on ice and transfer 100 ml of 
competent cells to the culture tubes and add 25ng of DNA to the 100 ml 
competent cells and quickly flick the tubes for several times. Place the tube 
immediately on ice for 10 minutes. Then heat-shock the cell mixture for 50 
seconds in a water bath at 42 degrees. Afterwards place it back to ice for 
another 2 minutes. Add 900 ml of cold SIC medium to the cell suspension and 
incubate for 60 minutes at 37 degrees in a shaker. Finally cells were diluted to 
1:10 and 1:100 and plated on LB agar ampicillin containing plates. Plates 
were placed to an incubator at 37 degrees for overnight. Then pick two clones 
for overnight growing by placing it back to the shaker at 37 degrees. Plasmid 
DNA was purified by using a Miniprep from QIAGEN. The size of the plasmid 
is checked via agarose gel. HEK293T cells were cultured a day prior to 
transfection. Dilute plasmid to 250 mg/ ml and all miRNA mimics and 
antagomiRs accordingly. Lipofectamine 2000 were incubated with Opti-MEM 
medium at room temperature for 5 minutes. Then mix this solution with the 
plasmid and mimic or antagomiRs. Incubate for 20 minutes at room 
temperature. Remove the medium from HEK293T cells and wash it twice with 
PBS. Then remove the PBS and add the transfection solution on top of it. 
Incubate for 24 hours and replace the transfection medium with a DMEM 
medium. After 48 hours luciferase assay can be performed.   
 
2.2.15 Luciferase assay 
The preparation for the measurements of the luciferase and renilla signals 
was done with the Dual-luciferase reporter assay kit from Promega. The 
protocol was followed according to the manufacturer’s instructions. 
Measurements were done at the Spectra Max M5 plate reader.   
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3 Results 
3.1 Four subpopulations within the immature mTEC pool  
In the past years researchers have been intensively trying to solve the 
conundrum how the development of mTECs is regulated and maintained in 
adulthood and what driving forces are present in mTECs to drive immature 
cells to maturation. The mTEC population can be collected by the following 
scheme, namely: DAPI-CD45-EpCAM+MHCII (Fig.4). Recently a study 
demonstrated that immature mTECs (MHCIIlow) can be subdivided into four 
subpopulations based on their surface expression of Sca-1 and CD24, calling 
them: double negative (DN), Sca1-CD24+ (CD24), double positive (DP) and 
Sca1+CD24- (Sca-1). These four subpopulations are different in terms of their 
ontogeny, long-term reconstitution ability, label retention and the capability to 
give rise to mature mTECs (Klug, 2013).  
 
Figure 4 The four subpopulations: The gating strategy to find the four subpopulations. Starting 
by the exclusion of duplets (FSC-W/ FSC-1A) and dead cells (DAPI). Followed by the inclusion of 
non-hematopoietic cells by excluding CD45 positive cells. Then gate for EpCAM positive cells 
because mTECs are EpCAM positive. Low MHC II expression indicates immature mTECs, 
therefore we gate for left bump. By using Sca-1 and CD24 we can segregate the four 
subpopulations. 
To understand the regulation of how immature mTECs are developing into 
mTECs it is necessary to understand those cells first and see what kind of 
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molecular driving forces are present to drive immature mTECs to become 
mature mTECs. To do so we started to look for the four subpopulations in 
different mouse strains such as severe combined immunodeficiency (SCID) 
mice, nude mice and Dicerflox/flox x FoxN1Cre mice (henceforth referred to as 
Dicer knockout (KO) mice). In all three strains we could identify a deficiency in 
the development of the four subpopulations as well as their potential to drive 
mTECs to maturation. SCID and Dicer knockout mice were further analysed to 
characterize their involvement in the mTEC development. As is hasn’t been 
shown how those four subpopulations relate to each other we compared their 
mRNA and miRNA expression levels to decipher a potential lineage 
progression towards mature mTECs. Potential functional miRNAs were 
selected and analysed, selected miRNA were proven for their relevance by 
using a SCID reconstitution model, potential to manipulate the development of 
the four subpopulations were investigated by overexpression and 
downregulation of miRNAs and finally finding their negative correlated mRNA 
targets and the relevance of those targets in the role of mTEC maturation.  
3.2 The four subpopulations in distinct mouse strains 
We have recently seen that Dicer KO mice show a decline in Sca-1 and DP 
subpopulations. This phenomenon could also be seen in other strains with a 
block in mTEC development, such as in nude and SCID mice. The distribution 
of the four subpopulations is always similar, no matter from which background 
they come from. Black6 and Dicer KO are sharing the same background, as 
well as SCID with balb/c or nude with NMRI (Fig.5). Also the percentages of 
mature mTECs are declined in those three mouse strains (Fig.6). In all wild 
types DP is the population, which has the highest percentage of cells (65 - 
85%), second biggest population is CD24 (14 - 24%), DN ranges between 0.4 
– 4% and Sca-1 is around 0.4 – 7%. In Dicer KO, SCID and nude mice the 
biggest population is gone, while the distribution in CD24 and DN increased 
dramatically. The percentage of DP (12 -18%) went down, while CD24 (76 – 
82%) and DN went up (0.6 – 12%), however the population of Sca-1 remained 
small (0.1 – 0.8%). Importantly to mention is that nude mice have a mTEC-
intrinsic genetic defect (a mutation in the transcription factor FoxN1), the 
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similar phenotype in the SCID model results from the absence of T cells, 
which influence the thymic epithelium development through the thymic 
crosstalk. Notably, this block ultimately leads to the absence or great 
reduction of terminally differentiated mature mTECs and impaired T cell 
selection in all three different mouse strains.  
 
Figure 5 Different mouse strains shows different patterns of the four subpopulations: Black6, 
balb/c and NMRI mice express a similar pattern of the four subpopulations where you find the 
biggest population residues in Sca-1+/CD24+. Dicer KO, SCID and nude mice show a totally 
different distribution, where the biggest population is inhabits in the Sca-1-/ CD24+ population. 
Even though the modifications made in Dicer KO, SCID and nude differ, the results of their 
distribution of the four subpopulations remain similar.  
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Figure 6 Development of mTECs: Normally mTECs can be divided in immature and mature 
mTECs (Black6 mice). Immature mTECs replenish the mature mTEC populations. In mouse 
strains such as Dicer KO, SCID and nude mice we saw an impairment of the four subpopulations 
thus effecting as well the development of mature mTECs.  
 
The remarkable similarity of the distribution of the four subpopulations 
between nude, SCID and Dicer KO mice hinting the fact that these 
subpopulations might represent sequential lineage progression stages of 
mTEC and that this lineage progression is dependent on two type of signals: 
cell-intrinsic and cell- extrinsic factors. It has been already published (Desanti 
et al. 2015) that mTEC maturation and development are depending on 
lymphotoxin and RANKL signals provided by several hematopoietic cells. 
Activation and inactivation of certain signalling pathways are also needed to 
ensure a proper mTEC development such as Notch and NF kappa b 
signalling. It is generally accepted that fine-tuning of intracellular signalling 
usually relies on posttranslational modulators such as miRNAs or long-non-
coding RNAs (lncRNAs) to act as switches.  
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3.3 The mRNA expression profiling of the four subpopulations 
To be able to determine the molecular mechanisms of mTEC lineage 
progression we performed mRNA and miRNA expression profiling of the four 
subpopulations of immature mTECs (Sca-1, CD24, DP and DN) and 
compared them to those of mature mTECs (high). This confirmed our 
hypothesis that those subpopulations are related to each other and eventually 
develop from each other. When we compare the mRNA expression levels and 
displayed the data in a dendrogram (Fig.7) we should see how the 
subpopulations are related to each other. One replicate from DP has been 
removed from all analyses as the sample turned out to be an outlier. DP and 
CD24 are close to each other as they have been paired, as well as DN with 
high. Sca-1 was not paired with any subpopulations thus leading to the 
conclusion that it may differ from the other subpopulations. Still we can 
assume that Sca-1 is closer to the two subpopulations DP and CD24 than to 
DN or high. Another demonstration of the relationship of all four 
subpopulations is shown in the unrooted tree (Fig.8). It endorses our 
hypothesis what we have seen already in the dendrogram, but also 
segregated the relationship between Sca-1, DP and CD24; as Sca-1 is closer 
to DP than to CD24. Taken together the data give us the hint that the 
subpopulation Sca-1 is different and might be a progenitor subpopulation, 
while DP acts as an intermediate stage between Sca-1 and CD24. The 
subpopulation DN is the closest to mature mTECs.  
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Figure 7 Dendrogram of mRNA profiling: The data have been generated with R. mRNA 
expression data, which were generated with mRNA microarray analysis, have been used for this 
analysis.  For each subpopulation 5 replicates have been used, except high and DP, where only 
4 replicates have been used. Each replicate consists of 24 mice, which have been used to pool 
the samples together.  
 
 
Figure 8 Unrooted tree of mRNA profiling: The unrooted tree is another illustration method to 
show the relationship between all five populations. Sca-1, DP and CD24 have similar mRNA 
expressions than DN and high. DN and high populations are more alike.  
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We did a principal component analysis (PCA) to see our findings from another 
perspective. The first component gives the highest degree of variability (48%) 
the mRNA expression data can give, while the next following component 
provides 15% of variability (Fig.9). Therefore the first two components were 
used to show the variability between the five populations. Different symbols 
have been used to represent the different populations, Sca-1 as a triangle, DP 
as a full coloured square, CD24 as an empty square, DN as a star and high 
as a circle (Fig.10). First it can be interpreted that all five populations are 
different from each other, as there is no overlap of two or more populations. It 
can be understood that the populations high and Sca-1 share the least 
similarity of mRNA expressions. As the population high have a high value of 
PC1 but a low value of PC2, whereas Sca-1 a high value of PC2 but an 
extremely low level of PC1. The interpretation of a potential developmental 
sequence or which populations are more alike is harder to read compared to a 
unrooted tree or a dendrogram.  
 
Figure 9: Principal Component Analysis: The percentage of variance in each principal 
component. PC1 contributes around 48%. Summing up all 24 PCs it will make up to 100%.  
mRNA without DP1 PCA
PC
Pe
rc
en
t V
ar
ian
ce
0
10
20
30
40
50
60
3	Results	
56	
  
Figure 10 PCA of the four subpopulations: The principle component plot with PC1 and PC2 is 
displayed here. There are no overlaps of the populations thus we conclude that all five 
populations are different from each other. Because PC2 covers only 15% variance, the 
difference between DP and Sca-1 is just minor.  
 
The Venn-diagram shows the number of genes that are unique for each 
subpopulation (Fig.11). Each subpopulation is compared to mature mTECs. 
The rationale behind this analysis is to reveal the numbers of unique genes 
between the populations. While Sca1-high represents 1381 unique genes, 
DP-high 1788 genes, CD24 only 486 and DN merely 324 unique genes, 
meaning that the difference between the mRNA expressions of each 
subpopulation to mature mTEC is getting less during the development. Thus 
we propose the following potential developmental sequence: Sca-1 à DP à 
CD24 à DN à mature mTECs (high). 
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Figure 11 Venn diagram of the mRNA profiling: When each subpopulation is compared to 
mature mTEC (high) we can see that Sca-1 has 1381 unique genes compared to high, whereas 
DN only 324 unique genes. Therefore a Venn diagram can provide hints how much different 
each subpopulation is compared to high.   
3.4 The miRNA expression profiling of the four subpopulations 
Besides the mRNA profiling we did also with the same biological samples a 
miRNA profiling, as we are interested to see the different miRNA expressions 
during the development. Interesting was to observe that the four 
subpopulations showed a very different clustering in the miRNA expression 
data compared to the mRNA expression data. When we looked at the miRNA 
expression levels between the subpopulations we noticed that always two 
subpopulations are sharing the same sets of miRNA, while the set of miRNAs 
in mature mTECs is clearly very different from the two clustered subsets 
(Fig.12). The dendrogram shows that Sca-1 and DN are sharing the same 
miRNAs, while DP and CD24 are sharing the same miRNA sets. These 
results are indicating that miRNA expressions vary from the gene expressions 
during the development of mTECs. These variations follow the common 
knowledge how miRNA interacts to regulate gene expressions (Neilson et al. 
2006). A developmental arrest can be seen as the four subpopulations are 
hampered and mature mTECs are not being developed or not being 
developed properly in the absence of miRNAs. Thus we are hypothesizing 
that miRNAs might play a role in the development of mTECs.  
mRNA Expression
Sca−high
CD24−high DN−high
DP−high
1381
486 324
1788
279
358
1555
238
745
107
301
1889583
355
5426
8324
3	Results	
58	
  
Figure 12 MiRNA profiling of the four subpopulations: The dendrogramm displays the five 
populations as a family tree. Where we can see that miRNAs from high are unique. DP is 
clustered with CD24, while Sca-1 is clustered with DN.  
 
When we looked at the PCA on the miRNA level the difference between the 
two clustered subpopulations look similar to the dendrogram (Fig.13). MiRNAs 
in mature mTECs are very different from those of the four subpopulations. 
Again we can see a clustering of always two subpopulations, Sca-1 with DN 
and DP with CD24. Mature mTECs have a high value of PC1. While Sca-1 
and DN have a high value of PC2, but a low value of PC1. And DP and CD24 
have both low levels of PC1 and PC2. The results provide an indication that 
high and the two clusters are different from each other.  
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Figure 13 PCA of miRNA profiling: The PCA plot shows a clustering of Sca-1 with DN, while DP 
groups with CD24. The plot hints that high and the two clusters differ from each other.  The per 
cent of variance in PC1 is 63% and in PC2 only 10%. Therefore the difference between DP/CD24 
are minor compared to Sca-1/DN. But the variance difference between DP/CD24 to high, as well 
as Sca-1/DN to high, are huge. 
 
The Venn-diagram for miRNAs (Fig.14) demonstrates the number of miRNAs 
from each subpopulation compared to high. Sca-1-high shows 13 exclusive 
miRNAs, as well as 13 unique miRNAs for DN-high. When comparing Sca-1-
high with DN-high there are 8 miRNAs Sca-1 and DP share with each other. 
CD24-high displays 17 unique miRNAs and DP-high counts 42 distinctive 
miRNAs. CD24 shares according to the Venn-diagram 63 exclusive miRNAs 
with each other.  
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Figure 14 Venn-diagram of the miRNA profiling results: Sca-1-high has 13 unique miRNAs, 
CD24-high 17 miRNAs, DN-high 13 miRNAs and DP-high 42 miRNAs. When we take two 
subpopulations together, Sca-1 and DN, we can see an overlap of 8 miRNAs while the two 
populations CD24 and DP have 63 common miRNAs with each other.  
 
Taking it all together miRNAs are present in the four subpopulations and show 
in miRNA clusters. We can see a clustering of miRNAs in Sca-1 with DN and 
DP with CD24. The miRNA set from mature mTECs seem to be different from 
the two clusters. The relevance of miRNAs in the development of mTECs still 
needs to be discovered.  
3.5 A developmental progression among the four subpopulations 
To look closer into the potential lineage progression sequence we looked into 
known markers, which have been published to play a role in mTEC 
development or TRAs (Fig.15). Known markers are such as CD80 (Akiyama 
et al. 2014), FoxN1 (O’Neill et al. 2016), Aire (Shi and Zhu, 2013), Pdpn, 
Gad1 (Rattay et al. 2016), Casein beta (Csnb), Trp63 (Wu et al. 2012), Pcp4 
(Goldfarb et al. 2016), Sirt1 (Chuprin et al. 2015), CCR4 (Laan et al. 2009), 
Meis1 (Hirayama et al. 2014) and Pax1 (Romano et al. 2013). By plotting the 
expression values of those genes into our sequence we could actually see a 
lineage progression, indicating that the population Sca-1 might come first, 
then develops further into DP. From DP it differentiates to CD24, while CD24 
becomes DN and very likely that DN becomes a mature mTEC. Just like the 
sequence, which we have observed.  
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Figure 15 Potential lineage progression sequence: By plotting known mTEC markers, which 
have been published in the literature to play a role in the mTEC development, we can actually 
see that our suggested lineage sequence among the four subpopulations supports our claim. 
We used 5 replicates for each subpopulations, except DP and high, were we used only 4 
replicates. 
 
By comparing the expression of thousands of genes in the four 
subpopulations we could reveal a potential sequence how immature mTECs 
develop over different steps to become mature mTECs. To endorse our 
hypothesis we used another method to propose the progression sequence, by 
using a FoxN1 eGFP mouse line (Fig.16). There we look specifically for the 
FoxN1 expression levels in the four subpopulations as well as in mature 
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mTECs (MHCII high) and compared the expression values of FoxN1 among 
those cell populations. It is known in the literature that FoxN1 is upregulated 
during mTEC maturation and that immature mTECs express very low levels of 
FoxN1. So we looked at the expression values of each population and we can 
reveal that Sca-1 (black) has a very minor FoxN1 expression, while DP (red) 
has an average expression level. CD24 (blue) is almost comparable with 
mature mTECs (violet), whereas DN (green) is not distinguishable from 
mature mTECs. Therefore we propose the following lineage sequence: Sca-1 
à DP à CD24 à DN à mature mTECs  
 
 
Figure 16 FoxN1 eGFP expression in the four subpopulations: FoxN1 is a known mTEC 
development marker. We used a FoxN1 eGFP mouse and checked the correlation between the 
FoxN1 eGFP signal and each subpopulation. This experiment has been done three times; each 
time one mouse was used.   
 
3.6 Finding the most prominent miRNAs in the development of 
immature mTECs 
To find the functional miRNAs, which are playing a role in the four 
subpopulations, data that have been collected by miRNA microarray analysis 
were used to find the most relevant ones. Afterwards those data were further 
processed in a PCA. Looking at the PCA results we saw a striking separation 
of miRNAs in the four subpopulations as well as in mature mTECs. In the PCA 
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we listed all miRNAs in different principle components (PCs) based on their 
percentage of variances (Fig.17). In the principal component 1 around 63% of 
miRNAs are showing exactly the phenotype that we have observed, clustering 
of CD24 with DP and Sca-1 with DN. PC 2 covers 10% of miRNAs and all 
following PCs are showing a less and less per cent of variances. All 24 PCs 
are summed up to 100%.  
            
Figure 17 microRNA sets with their per cent of variations: The percentage of variance in each 
principal component. PC1 contributes around 63%. Summing up all 24 PCs it will make up to 
100%.  
 
3.7 Verification of the potential miRNAs in different mouse lines 
From the PC1 be picked from the top of the list 25 miRNAs, as they seem to 
be the most prominent ones. Afterwards we ran a literature search to figure 
out whether those miRNAs have been mentioned to play a role in 
development, differentiation or are involved in a signalling pathway. 
Subsequently search for functional taqman primers for those miRNA 
candidates. Then we verify their existence in quantitative PCR (qPCR) in 3 
biological independent sorted cells. The results in qPCR revealed that only 16 
miRNAs are promising candidates. The other 20 miRNAs we have tested 
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failed to show a substantial signal. Thus we only proceed with those 16 
miRNAs, which are listed in the table (Tab.1). 
 
Table 1 Potential miRNAs from principal component 1: The most promising miRNAs after 
intensive literature search and qPCR.   
 
Interestingly, our miRNA candidates have different expression dynamics 
(Fig.18). Some of them (miR-200c-3p, miR-92a-5p, miR-34a-5p, miR-494-3p) 
are going up during lineage progression, some are (miR-877-3p, miR-125b-
5p, 125a-3p, miR-125a-5p, miR-205-5p) declining during maturation, while 
others (miR-709, miR-29a-3p, miR-203-3p, miR-34b-3p, miR-761, let-7c-5p, 
miR-125b-1-3p) are rising and falling during development. This kind of 
fluctuation of miRNA expressions might be important during the lineage 
progression thus worth to investigate further. To confirm our findings we went 
back to our miRNA microarray data and checked for the miRNA expressions 
of our candidate miRNAs. Indeed we saw the same dynamics in the 
microarray data as well.  
miRNA
mmu-let-7c-5p
mmu-miR-125a-3p
mmu-miR-125a-5p
mmu-miR-125b-1-3p
mmu-miR-125b-5p
mmu-miR-200c-3p
mmu-miR-203-3p
mmu-miR-205-5p
mmu-miR-29a-3p
mmu-miR-34a-5p
mmu-miR-34b-3p
mmu-miR-494-3p
mmu-miR-709
mmu-miR-761
mmu-miR-877-3p
mmu-miR-92a-5p
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Figure 18 Different miRNAs plotted in our proposed lineage sequence: The qPCR was done with 
freshly isolated RNA from three independent sorts, each time with 6 female mice pooled 
together.  
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After we have confirmed the existence of our miRNA candidates in Black6 
mice, we wanted to investigate their expressions in Dicer KO mice to see if 
their expressions are disturbed in those animals. In Dicer KO mice a shifted 
phenotype can be observed, where the biggest cell population in DP is 
extremely reduced while the cell population in CD24 is increased (Fig.19). 
Dicer KO mice have a loss of Dicer, an enzyme that cleaves pre-miRNA to 
become mature miRNA. If this fails all Dicer-dependent miRNAs are lost.  
 
Figure 19 Distribution of the four subpopulations in Dicer KO mice: Sca-1 positive cells are on 
the upper two quadrants. CD24 positive cells are on the lower right quadrant. Cells with Sca-1+ 
and CD24+ are called double positive (DP) and is displayed on the upper right quadrant.  Sca-1- 
and CD24- cells are on the lower left quadrant. A normal Black6 mouse has the biggest cell 
population in DP, followed by CD24+. While in Dicer KO mice the cell population CD24 becomes 
the biggest population and the population in DP drops dramatically.  
 
As Sca-1 and DN are minor subpopulations, we needed to pool two 
populations together to have enough material to run our qPCR analysis. We 
pooled the populations Sca-1 with DP and CD24 with DN. Indeed all miRNAs 
were missing or expressed in a low expression level compared to the wild 
type. The threshold cycle (CT) is shown between Sca-1 and DP versus CD24 
and DN in Dicer KO (left bar) and Black6 mice (right bar), respectively 
(Fig.20). As some miRNAs were not detectable their CT value is set as 40.   
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Figure 20 miRNA expressions in Dicer KO mice versus Black6 mice: For this experiment RNA 
were isolated from Black6 mice and Dicer KO mice. The experiment has been performed three 
times; each time 12 female mice were pooled. In all samples the difference between Black6 mice 
and Dicer KO mice were significant with a p-value <0.05 (t-test). Except for miR-200c-3p in 
CD24/DN sample and miR-877-3p in CD24/DN sample. 
CT 
Sca-1/DP	and	CD24/DN	in	Dicer	KO	vs.	Black6 
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The results are indicating that our miRNA candidates in Dicer KO mice are 
expressed in very low up to non-detectable levels when compared to the wild 
type Black6 mice. Indicating that those miRNA expressions are hampered in 
Dicer KO mice, probably inducing the phenotype changes in the four 
subpopulations. For this reason we continue with our 16 miRNA candidates. 
3.8 A dynamic model to follow the mTEC development 
The amount of 2x107 wildtype bone marrow cells, depleted for CD90.2, are 
injected intravenously into SCID mice (Fig.21) and the data indicated that 
bone marrow reconstitution in the adult SCID results in a restoration of the 
four subpopulations and reach their normal distribution after 8 weeks (Fig.22). 
The size of the reconstituted thymus is comparable to a young mouse thymus. 
The four subpopulations are back as well as a proper T cell development 
could be seen. Therefore, this experimental model is suitable to track adult 
mTEC lineage progression and thymus restoration.  
 
Figure 21 The four subpopulations in SCID mouse before bone marrow transplantation: MTECs 
are EpCAM positive cells therefore they have been gated. The four subpopulations can be found 
in MHCII lower part. Especially SCID mice do express a very low numbers of mature mTECs, 
MHC II high, therefore the cut between immature and mature mTECs can be segregated easily. 
In SCID mice the biggest subpopulation is CD24+ with a 81% distribution of all immature mTECs.  
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Figure 22 The four subpopulations after 8 weeks bone marrow transplantation: With the same 
gating strategy and a 8 weeks follow-up we can see an enrichment of EpCAM positive cells, but 
also two peaks in MHC II positive cells, indicating immature and mature mTECs. The bone 
marrow restored the function of mTEC development as well as the distribution of the four 
subpopulations. DP contains the biggest population of 87% like in Black6, balb/c or NMRI mice.  
 
3.9 A dynamic model to reveal miRNA changes during mTEC 
development 
The four subpopulations of mTECs, which represent distinct stages of mTEC 
lineage progression were isolated from the SCID thymi at different time points 
(3, 4, 5, 7 and 8 weeks) after bone marrow reconstitution, hence generating a 
time series of mTEC development during thymus restoration (Fig.23). Pooled 
wild type SCID mice show a 0.8%, 15.7%, 4.7% and 78.8% distribution, Sca-
1, DP, DN and CD24 respectively. A small change of distribution 3 weeks post 
bone marrow transplantation can be observed 0.1%, 22.5%, 0.24% and 
77.2%, Sca-1, DP, DN and CD24 respectively. After week 4 post bone 
marrow transplantation all three subpopulations increased their cell population 
(8.6%, 63.3%, 7.5%, Sca-1, DP and DN, respectively) except CD24 (20.6%) 
were we observe a decline. In week 5 the distributions of the four 
subpopulations look very similar to week 7 and week 8, indicating that during 
that time all four subpopulations have been recovered and the distribution of 
the four subpopulations are fixed. Sca-1 is around 0.4 -0.5 %, DP 73.2 – 
77.6%, CD24 21.1 – 25.6% and DN 0.63- 1.1%. The variation between week 
5 and week 8 are based on a t-test not statistically significant, p-values >0.05. 
The subpopulations Sca-1 and CD24 were statistically significant different 
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compared to SCID and/or previous time point until week 5 were only Sca-1 
significantly changed compared to week 4, based on a t-test with a p-value 
<0.05. The thymus of SCID mice following bone marrow reconstitution has not 
previously been analysed with respect to the regeneration of the four 
subpopulations of mTECs. With our SCID model we can identify the time-
frame of regeneration, which can be seen here as week 5 post bone marrow 
transplantation and therefore week 5 can be used as an end point of mTEC 
development. 
 
Figure 23 Time course after bone marrow transplantation: The development of the four 
subpopulations were observed over a time course of 8 weeks post bone marrow 
transplantation. In SCID mice the major subpopulation is CD24+. During the bone marrow 
reconstitution the four subpopulations are changing their distributions, especially Sca-1+ and 
CD24+ cells. This dynamic remained until week 5. Afterwards the percentage of distributions 
remains the same.  
The time frame until all four subpopulations was recovered could be also 
influenced by the regeneration of T cells. Therefore we checked for the 
generation of CD4 and CD8 T cells (Fig.24) as well as the expression of CD44 
and CD25 in DN T cells stage (Fig.25). It is clearly to see that the generation 
of CD4 and CD8 thymocytes are normal after 4 weeks of post bone marrow 
transplantations. While the expression of CD44 and CD25 of week 3 looks 
already similar to week 8, indicating that CD44 and CD25 expression of DN T 
cells are already back after 3 weeks. 
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Figure 24 T cell regeneration after bone marrow transplantation in SCID mice: The development 
of CD4+ and CD8+ T-cells during the bone marrow reconstitution over a time course of 8 weeks. 
After3 weeks CD4+/CD8+ cells can be found. After week 4 post-transplantation the T-cell 
repertoire is recovered.  
 
 
Figure 25 Development of CD44 and CD25 expression in T cells during bone marrow 
transplantation: The T cells, which are CD4-/CD8- are called double negative (DN) and can further 
sub-divided into their CD44 and CD25 expressions. CD44-/CD25+ lymphocytes undergo β-
selection and after the selection for a proper re-arrangement of their TCR-b chain locus further 
differentiation steps occur to develop to CD4+ and CD8+ lymphocytes (Divya, 2007).  
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Then we generated a graph (Fig.26) with the kinetics of the generation of the 
four subpopulations as well as the generation of T cells during a time period of 
8 weeks post bone marrow transplantation. Those distributions were 
compared with SCID and balb/c mice, where SCID acts as a starting point and 
balb/c as an end point to show how the distribution normally should be like.  
 
Figure 26 Time course of the generation of the four subpopulations and T cells: On the upper 
figure the development of CD4+ and CD8+ can be observed over a time course of 8 weeks. SCID 
is the starting before transplantation and balb/c is the mouse background of SCID but with an 
intact immune system. Therefore balb/c is used as a reference for an end point. We can note a 
dramatically change between CD4-/CD8-, called double negative (DN), and CD4+/CD8+, called 
double positive (DP) between week 3 and 4 post-transplantation. After week 4 all distributions 
remain stable. On the lower figure the development of the four subpopulations can be seen. The 
distribution among the four subpopulations change drastically between week 3 and 4 as well but 
the distribution itself start to become stable after week 5.  
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It is interesting to observe that the fully recovery of CD4 and CD8 T cells was 
reached after 4 weeks of post bone marrow transplantation, while the 
generation of the four subpopulations was reached after 5 weeks. We can see 
a shifted time point of one week. As it has never been observed how long it 
will take until the four subpopulations are recovered. With our findings we can 
claim that it takes around 5 weeks until their normal distribution of the four 
subpopulations is reached.  
3.10 Discovery of dynamic miRNAs during mTEC development 
The expression of our candidate miRNAs, which we picked in the previous 
experiments and selected based on several criteria, were analysed using a 
mouse model by inducing bone marrow transplantations in SCID mice and 
observe the development of our candidate miRNAs at different time points. 
The sorting needed to be adjusted, as the populations Sca-1 and DP are very 
small and are not adequate to run enough qPCRs. Thus Sca-1 and DP were 
pooled together (red rectangle), as well as CD24 with DN (blue rectangle) 
(Fig.27). In week 8 we isolated each subpopulation separately as Sca-1 
(violet), DP (orange), CD24 (green) and DN (pink), respectively. The scrutiny 
of changes of miRNA expression during thymus regeneration will provide 
important hints to categorize “early” and “late” miRNAs, which are involved in 
regeneration of the mTEC compartment.  
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Figure 27 Sorting strategy of SCID mice to isolate the four subpopulations: The sorting strategy 
to obtain RNA samples to run for qPCR of our miRNA candidates. Due to a small number of 
RNAs in Sca-1 and DN, Sca-1 has been pooled with DP, while DN with CD24. In week 8 enough 
RNA can be obtained from each subpopulation.  
Cells were isolated according to the isolation scheme above. RNA was 
isolated to verify our miRNA candidates during the SCID reconstitution on 
qPCR. Due to the low numbers of RNA samples we could only select few 
miRNA candidates to give an impression how dynamic miRNA expressions 
during development are. The selected miRNA candidates are: miR-125a-3p, 
miR-125b-5p, miR-200c-3p, miR-203-3p, miR-205-5p, miR-29a-3p and miR-
709. The expression levels of each miRNA during the reconstitution are 
displayed from week 0 until week 5 post bone marrow transplantation 
(Fig.28).  
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Figure 28 Dynamics of miRNAs during SCID reconstitution: The data shown here is part of the 
SCID reconstitution experiment where for each time point 24 SCID mice were injected with bone 
marrow. As a control PBS has been injected in another 24 SCID mice to serve as a control. Due 
to the low numbers of cells all four subpopulations were used and pooled as one sample. Then 
qPCR has been performed in three replicates. The results are shown in log base 5 scale.   
3.11 Investigation of the functional role of our miRNA candidates 
Interesting was to detect how dynamically the miRNA expression levels were 
during the SCID reconstitution, where mTECs have been gradually developed 
over the time course of 5 weeks. During that time period our candidate 
miRNAs have also undergone different expression levels. Thus we 
hypothesize that they might play a role during the development of the four 
subpopulations as well as having a role in maintaining the four subsets during 
adulthood. Therefore we wanted to investigate into those miRNAs by seeing if 
those miRNAs have a functional role. This can be investigated by 
manipulating the expression levels of mature miRNAs. To do so we are using 
a transient transfection method and transfect the tomato-red-labelled 
mTECslow with either mimics or antagomiRs for 12 to 14 hours. Afterwards 
cells were mixed with embryonic thymic stroma from E14.5 old embryos and 
put into a culture system called re-aggregation thymic organ culture (RTOC) 
to harbour our cells for culture and give them a 3D culture microenvironment, 
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which those cells need to survive (Fig.29). After 4 days of cell culture cells 
were analysed with flow cytometry.  
 
Figure 29 RTOC cultivation system: MTECs are primary isolated suspension cells and do not 
have ability to grow or to be maintained in the standard tissue culture. Therefore we use the 
RTOC system to cultivate our cells for a long period to be able to detect the miRNA changes we 
have induced. Our sorted cells are tomato-red labelled cells and transfected either with miRNA 
mimics, miRNA antagomiRs or siRNAs using a transient transfection method and then left for 
12-14 hours in the well plates. After 12-14 hours cells were washed and mixed with digested 
embryonic thymi and placed on the top of a membrane. After 24 hours the cells form a 3D 
capsule where mTECs can grow and differentiate. After 4 days cells will be analysed with flow 
cytometry.  
3.12 Transfection methods on primary cells 
Primary cells are cells, which are hard to transfect and we tried different 
transient transfection reagents (Fugene, lipofectamine, Dharmafect and 
viromer Blue) to test the transfection efficiency and the viability (live and dead 
dye) of the cells after transfection (Fig. 30).  
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Figure 30 Transfection method: Different transient transfection reagents have been used and 
checked for their GFP expression after 12 hours of incubation. Left side control, right side 
transfected cells, 2 replicates. 
We also approached a lentiviral transfection with GFP, incubated the cells for 
24 hours and measured their viability and GFP expression levels. Even 
though the transfection efficiency was 60% the viability of the cells were very 
poor (Fig.31 and Fig. 32).  
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Figure 31 Transfection method lenti viral: A lentiviral transfection has been tested. The GFP 
expression level is high, unfortunately an incubation of 24 hours reduces the cell viability 
extremely, 2 replicates 
 
 
Figure 32 Viability of cells after transfection: The viability was meassured with DAPI. Left side 
transfected cells with lentivirus with a viability of 25% after 24 hours and on the right side with 
viromer Green with 88% living cells after 24 hours transfection, 2 replicates. 
 
After several trials we decided to use a polymer-based reagent, called viromer 
Green that mimics a viral infection, which can promote an active endosome 
escape that will lead to a cytosolic delivery of our reagents. The transfection 
efficiency was measured by siGlo GFP, a fluorescence oligonucleotide duplex 
that localizes to the nucleus). SiGlo has the same length of a miRNA tagged 
with a GFP, thus provide us the ability to measure the efficiency of the 
transfection by measuring the GFP signal by flow cytometry. MTECs were 
isolated according to the mTEC isolation protocol and after the isolation cells 
were transfected with Viromer Green and siGlo for 12 hours. After 12 hours of 
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incubation cells were analysed by flow cytometry. We have reached a 
transfection efficiency of over 75% and 95% of our cells were viable. 
Therefore this method is efficient as well as suitable for our primary isolated 
cells (Fig. 33).  
 
Figure 33 Transfection efficiency with viromer Green: The transfection efficiency was measured 
after 12 hours incubation of viromer Green with either PCS (control) or with siGlo (green 
fluorescence dye). The efficiency with viromer Green and siGlo was 75%. 
3.13 Transfection efficacy of mimics and antagomiRs in mTECs 
The next step was to figure out how well miRNA mimics or antagomiRs 
perform after the transfection to guarantee an up- and downregulation of a 
specific miRNA. To show the efficacy we have cells that are only transfected 
with the transfection reagent itself, with a scramble miRNA used here as a 
negative control, a mimic or an antagomiR. The list of miRNA mimics (Tab.2) 
and antagomiRs (Tab.3) are listed below.  
miR-125a-3p miR-125a-5p miR-125b-1-3p miR-125b-5p 
miR-200c-3p miR-203-3p miR-205-5p miR-29a-3p 
miR-34a-5p miR-34b-3p miR-494-3p miR-709 
miR-761 miR-877-3p miR-92-5p  
Table 2 List of mimics: The candidate miRNAs we have chosen are listed above and cells have 
been transfected with those mimics.  
 
3	Results	
80	
let-7c-5p miR-125a-3p miR-125a-5p miR-125b-1-3p 
miR-125b-5p miR-200c-3p miR-203-3p miR-205-5p 
miR-29a-3p miR-34a-5p miR-34b-3p miR-494-3p 
miR-709 miR-761 miR-877-3p miR-92-5p 
Table 3 List of antagomiRs: The candidate miRNAs we have chosen are listed above and cells 
have been transfected with those antagomiRs. Let-7c-5p has been chosen to be a positive 
control.  
 
Transfected cells with miRNA mimics and antagomiRs were incubated for 14 
hours, washed and then kept in culture for four days until their RNA were 
isolated. Afterwards qPCRs were performed to track the miRNA level changes 
between different samples. Overall we could show that the efficiency of the 
antagomiRs display a fully inhibition of the endogenous miRNA. While mimics 
raise the miRNA level up to thousand fold. Even though the scramble miRNA 
should not be affecting the cells, as the sequence is scrambled, still we can 
see a small interference in affecting the miRNA levels, but importantly not as 
effective as a mimic or an antagomiR (Fig. 34, 35).   
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Figure 34: Efficiencies of transfection:  In this experiment freshly isolated immature mTECs 
were transfected with either PBS (no transfection), scramble miRNA (negative control), let-7-c 
(positive control), miRNA mimic or miRNA antagomiR. This experiment has been done with two 
replicates. Then samples were collected and RNA was isolated from the cells. QPCR was 
performed with two replicates, each replicates consists of 3 biological replicates. Not only the 
transfection efficiency can be seen, but also the overexpression and downregulation of our 
miRNA candidates. The expressions between the samples no transfection and negative controls 
were statistically not significant, p-values were > 0.05.  
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Figure 35: Efficiencies of transfection second part: The same experimental approach has been 
done as shown above. 
 
3.14 Further adjustments and optimization of cell numbers and 
controls  
Originally we have planned to transfect from each subpopulation a minimum 
number of 150 000 cells. It was a suggested cell number from the company’s 
manual protocol. Due to the low amount of Sca-1 and DN cells extracted from 
24 mice this cell number was not realistic. It would not be ethically correct to 
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increase the size of mice to gain such high number from each subpopulation. 
We would need to increase three times the size of mice, as for 24 mice the 
yield of cell numbers in Sca-1 and DN would be only 50.000. Thus we sorted 
only for immature MHCII low mTECs tomato red labelled (red rectangle), 
transfected those cells without sorting all four subpopulations separately to be 
able to screen all miRNA candidates (Fig.36). This give us unfortunately the 
disadvantage for not being able to see the effect of each miRNA affecting 
each subpopulation during the maturation, especially in regards of their 
lineage progression from one subpopulation to the next one. Nevertheless we 
will see if the miRNA can functionally change the phenotype of four 
subpopulations from a wild type to a more Dicer KO or SCID phenotype.  
 
Figure 36 Sorting strategy of tomato red labelled mTECs: Gating strategy from sorting each 
individual subpopulation was changed to sort the entire immature mTECs. This increases the 
cell numbers in total. 
 
For the judgment of a successful transfection with either a mimic or an 
antagomiR we used for the negative control a scramble miRNA, as a positive 
control we looked for a certain miRNA, which can generate a resemblance of 
the four subpopulations in Dicer KO or SCID. It has been reported in the 
context of mTECs that Hmga2 is regulated by let-7. Hmga2 is one of the many 
genes, under the control of AIRE, which influences the expression of certain 
peripheral tissue antigens (PTA) that is normally expressed on mTECs during 
their development (Oliveira et al. 2016). And this miRNA has been 
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recommended by the website of thermofisher to be suitable as a positive 
control as endogenous let-7c miRNA is known to negatively regulate High 
Mobility Group AT Hook 2 (HMGA2) (Shell et al. 2007). HMGA2 is 
ubiquitously expressed, a non-histone and is known to act as a transcriptional 
activator that can change the translation of genes through changing the 
chromatin structure. Our group has observed that the chromatin structure of 
mTECs is more opened during the development (not published yet, Rattay) 
thus changing the chromatin structure will cause disruption in the mTEC 
development. Consequently we thought that using let-7c might disturb the 
development of the four subpopulations. Surprisingly a downregulation of let-
7c did show a disturbance in the distribution of the four subpopulations 
(Fig.35).  
 
Figure 35 The distribution of the four subpopulations in Black6 mouse vs Black6 with let-7c: In 
this experiment we compared the distribution of the four subpopulations between immature 
mTECs from a Black6 mouse and mTECs from a Black6 mouse transfected with let-7c 
antagomiRs for 12 hours. Analysis with flow cytometry has been done post 4 days transfection 
(right picture) and 4 days cultivation without transfection (left picture). The experiment has been 
performed only once. 
 
To ensure the same distribution of the subpopulations before and after 
transfection as well as four days tissue culture conditions we checked for their 
distributions in flow cytometry. Those cells were only transfected with the 
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transfection reagent viromer green, from this point will be called, wild type 
control.  
 
Figure 36 Distribution of the four subpopulations at different conditions: Here we are showing 
the distribution of the four subpopulations before the transfection, post-transfection after 12 
hours and post-transfection after 4 days. The distribution of all three different time points is 
similar. While the before transfection has a lower DP population and a higher CD24 distribution 
compared to the transfected cells, but there are no significant differences between post 12 
hours and post 4 days.  
When we compare the distribution of each subpopulation between the wild 
type control and the negative control we do not see a difference between 
those samples (Fig.36). Thus our negative control is safe and will not cause a 
shift in our subpopulations. We also used the same isolated cell pool and 
transfected them with either a negative (Fig.37) or a positive control (Fig.38) 
and analysed them after 4 days.  
CD24
Sca-1 
Before	transfection 
After	transfection	(12	hours) 
Post	4	days	transfection 
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Figure 37 mTECs transfected with a negative control in 3 replicates: The distribution of the four 
subpopulations after the transfection of a negative control, a scramble miRNA. Here three 
independent replicates are displayed. The analysis with the flow cytometry has been performed 
after post 4 days transfection. 
 
Figure 38 mTECs transfected with a positive control: The distribution of the four subpopulations 
after the transfection of a positive control, antagomiRs of miRNA let-7c. Here three independent 
replicates are displayed. The analysis with the flow cytometry has been performed after post 4 
days transfection. 
When we analysed the positive control where cells were transfected with an 
antagomir of let-7c, we could see a significant difference between two of the 
four subpopulations when comparing wild type with the positive control 
(Fig.39). The shift of the four subpopulations resembles the change of 
CD24 
Sca-1 
CD24 
Sca-1 
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population distributions in both SCID and Dicer KO mice. Therefore we found 
a positive control, which we can trust that can induce a shift in the four 
subpopulations to use as a positive control for the transfection efficiency as 
well as found a miRNA that could be relevant in terms of regulating the 
immature cells within the four subpopulations. 
 
 
Figure 39 Wild type control versus negative or positive control: The experiment has been 
performed three times with three independent replicates. Analysis with flow cytometry has been 
done post 4 days transfection. The picture above shows the wild type control with transfection 
reagent without mimics or antagomiRs versus transfection with a negative control (scramble 
miRNA). The picture below shows the wild type control with transfection reagent without mimics 
or antagomiRs versus transfection with a positive control (antagomiRs let-7c).  The distribution 
changes of the four subpopulations has been analysed with a t-test. Wild type control versus 
negative control shows no statistical significance. While the wild type control versus positive 
control shows a very high significance of p< 0.001.  
3.15 A change in the miRNA level has an impact in the four 
subpopulations  
The next step of our approach was to transfect our tomato red labelled 
immature mTECs with either a mimic or antagomiR. Then we compared the 
cell distribution of each subpopulation to the wild type control. The 
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experiments have been performed with three independent replicates. The 
results of the transfections with mimics and antagomiRs were very different. 
One miRNA, miR-203 (Fig.41), did not show any statistical changes in the 
four subpopulations when transfected either with mimics or antagomiRs. 
Some miRNAs such as miR-125a-3p (Fig.40), miR-200c (Fig.41), miR-205 
(Fig.42), miR-494 (Fig.44) and miR-877 (Fig.45) did not show any distribution 
changes in the four subpopulations while transfected with a mimic, but with 
their respective antagomiRs we saw statistical significances (t-test based) p> 
0.05. The statistical significances were from * = p>0.05, ** = p>0.01 and *** = 
p>0.0001. Other miRNAs such as miR-125b-5p (Fig.40) and miR-34a-5p 
(Fig.43) did not show any distribution changes when transfected with an 
antagomiRs, but when transfected with a respective mimic it did show a 
statistical significance. Interestingly we saw in five miRNAs miR-29a (Fig.42), 
miR-34b-3p (Fig.43), miR-709 (Fig.44), miR-761 (Fig.45) and miR-92a-5p 
(Fig.46) in both mimics and antagomiRs significant changes in the 
distributions of the four subpopulations. Some miRNAs need a tight regulation 
of their endogenous miRNA levels such as miR-29a, miR-34b-3p, miR-709, 
miR-761 and miR-92a-5p because an imbalanced level of these miRNAs can 
induce either an increase or a decrease of DP and CD24, while the other 
remaining 7 miRNAs can only influence the four subpopulation with either an 
overexpression or a downregulation of the miRNA. Taken together 12 
miRNAs seem to be relevant to play a role in the development of the four 
subpopulations.  
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miR-125a-3p and miR-125b-5p 
 
Figure 40 The effect of overexpression and downregulation of miR-125a and miR-125b: In this 
experiment we used three independent replicates either transfected only with the transfection 
reagent but without any mimics or antagomiRs, called wild type control, transfected with a 
miRNA mimic or transfected with an antagomiR. Based on the t-test we saw either no statistical 
significance (ns) p>0.05 and *** = p<0.001. 
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miR-200c and miR-203 
 
Figure 41 Effect of an overexpression and a downregulation of miR-200c and miR-203 Based on 
the t-test we saw either no statistical significance (ns) p>0.05 and * = p<0.05. 
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miR-205c and miR-29a 
 
Figure 42 Effect of an overexpression and a downregulation of miR-205 and miR-29a Based on 
the t-test we saw either no statistical significance (ns) p>0.05, * = p<0.05 and ** = p=<0.01. 
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miR-34a and miR-34b 
 
Figure 43 Effect of an overexpression and a downregulation of miR-34a and miR-34b Based on 
the t-test we saw either no statistical significance (ns) p>0.05, * = p<0.05 and *** = p<0.001. 
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miR-494 and miR-709 
 
Figure 44 Effect of an overexpression and a downregulation of miR-494 and miR-709 Based on 
the t-test we saw either no statistical significance (ns) p>0.05, * = p<0.05, **= p< 0.01 and *** = 
p<0.001. 
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miR-761 and miR-877 
 
Figure 45 Effect of an overexpression and a downregulation of miR-761 and miR-877 Based on 
the t-test we saw either no statistical significance (ns) p>0.05, **= p< 0.01 and *** = p<0.001. 
3	Results	
95	
miR-92a  
 
Figure 46 Effect of an overexpression and a downregulation of miR-92a Based on the t-test we 
saw either **= p< 0.01 and *** = p<0.001. 
 
3.16 Search of mRNA targets  
We have chosen the following miRNAs based on their high significant 
differences between wild type control and the manipulated miRNA: miR-125a-
3p, miR-125b-5p, miR205, miR-29a-3p, miR-34a-5p, miR-34b-3p, miR-709, 
miR-761, miR-877-3p and miR-92a-5p. For those miRNAs our statistic 
collaborators from UCLA (Dr. M. Pellegrini and Dr. W. Yan), have generated a 
list of mRNAs, which are negatively correlated to our miRNAs. Dr. Yan has 
generated a further list where the miRNA candidates and its negatively 
correlated targets have been verified and/or published, thus to diminish false 
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outcomes. For example miR-125b-5p has been already published targeting 
Bak1 in prostate cancer (Shi et al. 2007) and Mapk14 in Salmonella infection 
pathway (Yao et al. 2016). Based on those two lists we have selected for 
each miRNA 2-4 negatively correlated targets, which have a negative 
correlation score between -0.60 until -0.99 (Tab.4).  
 
miRNA  candidate 1 candidate 2 candidate 3 candidate 4 
miR-125a-3p Psmb11 Ubac1 Fam83e  
miR-125b-5p Apln Bak1 Mapk14 Arid3b 
miR-205 Dhcr24 Grtp1     
miR-29a Dcx Col4a4 Fgf23 Sirt3 
miR-34a-5p Bcl6 Rab11b Foxp1 Sall4 
miR-34b-3p Tbx5 Fbxo45 Sirt1 Abcb1b 
miR-709 Egr2 Jun Zfp113 Sgms2F 
miR-761 Rps15a Acsbg2     
miR-877 Tirap Rab11b Fli1 Dusp7 
miR-92a Btg2 Trp63 Zfp300  
Table 4 Selected mRNA targets:  For each miRNA we selected based on several criteria their 
potential mRNA targets.  
In total we selected 34 mRNA targets and have ordered for those designated 
targets adequate siRNAs.  
3.17 Quick screening of mRNA targets  
To be able to tell that a certain mRNA target has an influence on the 
development of the four subpopulations, all 34 mRNA targets are under 
scrutiny. For all 34 mRNA targets siRNA have been tested twice in freshly 
isolated tomato-red labelled immature mTECs. 
After 34 mRNA targets have been screened for their functional impact on the 
development of the four subpopulations we found only four mRNA targets 
which show a change in the distribution of the four subpopulations. Whereas 
the subpopulation in control populates 82.4% cells in DP, the positive control 
(let-7c antagomiRs) reduced the DP subpopulation to 20.9%, Bak1 siRNA to 
61.9%, Foxp1 to 59.9%, Mapk14 to 49.0% and Fam83e to 44.4% (Fig.47). 
3	Results	
97	
None of the mRNA targets can reduce the DP subpopulation as much as a 
let-7c antagomiRs, but still we found in Fam83 a reduction of DP up to 50%.  
 
Figure 47 potential mRNA targets: Immature tomato red cells were transfected with PBS 
(control), with let-7c antagomiR (positive control), Bak1 siRNA, Foxp1 siRNA, Mapk14 siRNA and 
Fam83e siRNA. The expression of the four subpopulations changes differently.  
 
As all four show a significant difference in the four subpopulations after an 
inhibition of the mRNA targets (Fig.48), we continued to verify their binding 
capability to their predicted miRNA targets via a luciferase assay. To amplify 
the gene of interest with the binding site of our miRNA candidate we 
generated primers with additional restriction enzyme sites for Pmel and Xbal. 
We also generated mutated binding sites to disrupt the binding of the miRNA 
to the candidate target. The inserts were ligated to a pmirGLO dual-luciferase 
vector, which has both luciferase and renilla luciferase. Plasmid were 
transfected to HEK293T cells and incubated to 48 hours. Afterwards the 
luciferase and renilla luciferase signals were measured and normalised. The 
results are indicating that Bak1 and Mapk14 are regulated by miR-125b-5p, 
while Foxp1 by miR-34a-5p and Fam83e by miR-125a-3p (Fig.49). 
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Figure 48 Statistical analyses between negative control and mRNA candidate: Each pair has 
been tested for their statistical significance (two-tailed t-test). Each experiment has been 
performed three times with three independent replicates. The negative control was viromer 
Green transfected with PBS and the positive control a transfection of viromer Green with let-7c 
antagomiR. NS = not significant, *= p<0.05, **= p<0.01 and ***= p<0.001.  
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Figure 49 Luciferase signal: We have tested the luciferase signals between the mRNA gene + 
mimic control (empty vector), mRNA gene + potential miRNA candidate and mRNA gene 
mutated + potential miRNA candidate. The signals were normalised based on the renilla signal.  
To verify these findings we isolated immature mTECs and transfected them 
either with no transfection reagent, a negative control, miRNA antagomiR or 
mRNA siRNA. After 2 days we checked their expression levels using qPCR 
(Fig.50). The results show the negative correlation between our miRNA and 
its mRNA candidate.  
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Figure 50 Negative Correlation miRNA and mRNA expression levels: To proof the efficacy of the 
transfections with mimics, antagomiRs or siRNAs respectively, we isolated the RNA from 
different samples and checked their mRNA and miRNA levels: Control - no transfection (only 
viromer Green and PBS) detects the candidate miRNA expression level. Negative control 
(viromer Green and scramble miRNA) detects the expression level of candidate miRNA. 
Inhibition of candidate miRNA (viromer Green and antagomiR) detects expression level of 
candidate miRNA. Inhibition of candidate miRNA detects the expression level of target mRNA. 
Control – no transfection (viromer Green and PBS) detects the target mRNA expression level. 
Inhibition of target mRNA (viromer Green and siRNA) detects the expression level of target 
mRNA. 
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4 Discussion  
 
The proper maturation of mTECs is an essential process for the T cell 
development and selection of auto-reactive T cells. Nonetheless, the 
molecular mechanism, which influences the development of mTECs is still 
poorly understood. Previous studies reported stem cell like cells, called 
thymospheres, which have the ability to give rise to bipotent thymic epithelial 
cells (Ucar et al. 2015), either develop further to mTECs or cTECs. The 
development of immature mTECs to mature mTECs is well known. Recently 
our group described the separation of immature mTECs into four new 
subpopulations by using expression markers such as CD24 and Sca1 to 
further distinguish the immature mTEC population and to category their 
developmental status. Those four subpopulations have been studied in 
embryos as well as in newborns but not in adulthood (Klug’s dissertation 
2013). The results have shown that all four subpopulations are distinct with 
respect to their ontogeny and their ability to give rise to mature mTECs ( 
unpublished, Klug). In the recent years microRNAs received an important 
status in the field of thymus and mTECs (Papadopoulou et al. 2012; Khan et 
al. 2015). In addition, it has been reported that Dicer knockout mice resulted 
to a disruptive medulla organization, loss of pGE and a shifted distribution of 
mTECs from mTEChigh to mTEClow (Ucar et al. 2013). 
This work aimed for a further understanding of the involvement of miRNAs in 
the maturation of mTECs, in particular the development of the four 
subpopulations from the immature mTEC population pool. To discover 
potential miRNAs related to mTEC maturation, immature mTECs, segregated 
into four subpopulations, and mature mTECs were analysed using microarray 
and bioinformatics analyses as well as different mouse models. These 
approaches led to the discovery of new miRNAs and their target mRNAs, 
specially needed during the development of immature mTECs and have a 
functional role to drive the development within the immature subsets, which 
would not have been obvious just by comparing the difference between 
mTEClow and mTEChigh populations.  
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4.1 Identifying a lineage progression within the four 
subpopulations 
Initially the four subpopulations were discovered in embryonic and neonatal 
stages but have never been defined in adulthood. Thus we looked closer to 
the distribution of the four subpopulations in Black6 mice at the age of 6-8 
weeks. Furthermore other mouse strains were under scrutiny, especially 
those that have an impaired mTEC development such as SCID and nude 
mice so see if we can find a hint for their impairment. We expected to see a 
difference in the distribution of the four subpopulations within nude, SCID and 
Dicer KO and Black6 mice. The reason for this assumption is the following. 
Nude mice have absent/vestigial thymus thus resulting to no mature T-
lymphocytes and harbour only limited numbers of mTECs. SCID mice have an 
impairment of the recombination of antigen receptor genes, which causes an 
arrest of T-lymphocytes, therefore T-lymphocytes are missing to migrate to 
the thymus, while the thymus is existing but is impaired to due the lack of a 
thymus-crosstalk. Whereas Dicer KO mice have a functional thymus and a 
proper T-lymphocyte development, but those mice are lacking of mature 
miRNAs in the thymus. Due to the fact that all three mouse strains have a 
deficiency from different sites, therefore it would not be surprising to see a 
difference in their distribution of the four subpopulations. Surprisingly the 
distribution of the nude, SCID and Dicer KO mice have a similar allocation of 
all four subpopulations. Whereas the biggest population in Black6 mice is 
represented in DP, the major subpopulation DP in the other three mouse 
strains decreased dramatically and shifted to CD24.  
To understand why populations are shifting and to decipher the relevance of 
the four subpopulations in terms of a potential lineage development of 
mTECs, which have been observed in embryonic and neonatal mice (Klug, 
unpublished), it needed to be figured out how those subpopulations relate to 
each other. Hence all four subpopulations (Sca-1, DP, CD24 and DN) and 
mature mTECs (MHC II high, referred as high) were isolated, their RNA 
extracted and microarray analysis on mRNA and miRNA levels were done. By 
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taking the mRNA expression data from all four subpopulations and mature 
mTECs our collaborator was able to create a lineage progression sequence 
with all five populations. The sequence based on the dendrogram is: Sca-1 à 
DP à CD24 à DN à high. It is clearly that Sca-1 is very different compared 
to the other subpopulations, while DP and CD24 as well as DN and high are 
more related to each other. Sca-1 might be the earliest population and DN is 
latest stage before becoming mature mTECs. To verify this hypothesis each 
of the four subpopulations were placed individually into a RTOC system and 
analysed after 7 days. The rational behind this experiment was to see if the 
lineage sequence we have gathered could be true. Unfortunately all four 
subpopulations, when placed individually into the RTOC system was able to 
give rise to the remaining three populations (not shown here). That could be 
the reason that the gates, which were set during the cell sorting was not 
stringent enough or an alternative could be that our two markers Sca-1 and 
CD24 are not enough to exclude other subpopulations within the immature 
mTECs which also have the potential to give rise to mature mTECs. Thus 
more markers are needed to get a better picture in how many different stages 
immature mTECs undergo before they become mature mTECs. Although the 
sequence could not be verified through in vivo experiments we used two other 
approaches to show that the sequence we have gathered could be real. The 
first approach was to look into known markers, which have been linked to the 
mTEC development to see if the sequence: Sca-1 à DP à CD24 àDN à 
high matches with the mTEC maturation. All eight markers CD80, FoxN1, 
Aire, Gad1, Csnb, Pcp4, Sirt1 and CCR4 should increase during the mTEC 
development, while the four markers Pdpn, Meis1, Px1 and Trp63 should 
decrease during the maturation. Indeed we see a lineage progression when 
we checked the levels of mRNA expression of those 12 markers in our five 
populations. We also used a FoxN1 eGFP mouse to detect the levels of 
FoxN1 expression by using flow cytometry. The results are showing the same 
outcome that the expression of FoxN1 follows the same sequence as we 
found in our microarray analysis.  
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4.2 Clusters of miRNA sets in the four subpopulations 
The data of the miRNA microarray analysis revealed three different miRNA 
sets. One identical miRNA set shared by DP and CD24 and another one by 
Sca-1 and DN, while high has its own miRNA set. It is already known in the 
literature (J. Shim and J. Nam, 2016), that changes in the miRNA expression 
will lead to mRNA changes as well as it can lead to differentiation of cells.  
The first set of miRNA is activated potentially to drive Sca-1 cells to become 
DP. As DP and CD24 share the same miRNA set and their development goes 
from DP to CD24, it could be the reason that DP is just a short intermediate 
stage and cells are moving quickly to CD24 without activating any miRNA sets 
to drive differentiation. To differentiate CD24 cells to DN another miRNA set 
needs to be activated. Then again the miRNA set “ Sca-1 and DN” needs to 
be activated to move those cells further to become mature mTECs. Therefore 
we believe that in those three mouse strains (Dicer KO, nude and SCID mice) 
miRNAs are not properly expressed due to an impaired mTEC development 
or even being absent as Dicer is missing to process immature miRNAs to 
mature miRNAs, thus we see no cells accumulating in Sca-1, an arrest of cells 
halted in CD24, as well as an almost non existing number of mature mTECs, 
because those internal miRNA switches are not activated. Certainly a specific 
set of miRNAs is needed to drive the bipotent progenitor cell to become Sca-1 
positive cells, as the developmental stage between the bipotent progenitor cell 
to become a mTEC is still unknown, no early stage before Sca-1 could be 
used to manifest this hypothesis that miRNA might play a role. As it has not 
been investigated how the expression of those miRNA sets are regulated and 
whether feedback loops are integrated within the four subpopulations to 
ensure a constant flow of immature mTECs to replenish the mature mTEC 
pool, this would be something which needs to be done to get a better 
understanding of the whole differentiation process.  
Hypothesizing that mTEC lineage progression occurs in a miRNA-dependent 
manner. It would make sense that when a certain set of miRNA is upregulated 
during development that it cause changes in the mRNA expression of the next 
subsequent population for instance when the miRNA set in CD24 is changing 
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due to external signals/factors, that might cause mRNA expression changes 
leading to a conversion of CD24 cells to DN cells, when assuming the 
sequence lineage progression we are claiming is in that order. It is known in 
the literature (Winter et al. 2009) that miRNA expression changes would 
proceed to mRNA changes, which then leads the cell to differentiate and that 
is what we believe what we are observing here. These results are suggesting 
that the miRNAs in the four subpopulations might be part of the molecular 
drive to move mTEC lineage progression forward. 
Taken all mRNA and miRNA data into consideration we are proposing the 
lineage progression sequence where Sca-1 is probably the most progenitor 
cell population from all four and develops to DP. DP is the population, which 
suffers the most severe loss of cells when T cell development is hampered or 
miRNAs are missing. This population populates the most cells within the four 
subpopulations. According to our analysis DP develops further to CD24. In 
CD24, cells are arrested in this stage when the maturation of T cells and 
miRNAs are impaired. Normally CD24 inhabits the second biggest population 
within the four subpopulations, but when signals from T cells and miRNAs are 
missing, cells tend to get stuck in this stage. The explanation on the miRNA 
level could be that as DP and CD24 are sharing the same sets of miRNAs, 
which is missing in Dicer KO mice. The progress of DP cells to become CD24 
is not disturbed, but from CD24 on another miRNA set is needed to process 
the CD24 subpopulation to DN, which explains why the population is 
accumulated in CD24. Certain miRNAs from the Sca-1 and DN miRNA set are 
probably needed to let the CD24 cells to move forward to become DN cells, 
as well as cells from the DN population to become mature mTECs. It could be 
the reason that certain miRNAs are regulating specific checkpoint molecules 
or targets in diverse signalling pathways, which have an influence for the 
mTEC development. And as immature mTECs have to replenish the mature 
mTEC population, cells need to be ready for the maturation. Theoretically it 
could be that the DP population normally gets a signal to progress further to 
become CD24 and that this progress is regulated. Then the CD24 cells get 
another signal to progress further to DN. As cells are arrested in CD24 and 
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DN it would be that it gives a certain signal that there are enough maturing 
cells in the thymus and that there is no need for a replenishment of immature 
cells that could be the reason why the Sca-1 population is fully missing. It is 
known that miRNA act as a positive or negative feedback loop as well as 
switches in differentiations. Thus it would make sense, that missing miRNA 
will lead to an arrest of the development of immature mTECs to mature 
mTECs. As the shift of the four subpopulations also occurs in mice lacking T 
cells, it could be that certain signals coming from the T cells are needed to 
activate gene expression of particular miRNAs, which are needed for the 
checkpoints on Sca-1, DP, CD24 and DN. Thus finding the miRNAs, which 
are playing an important role to drive the maturation of immature mTECs to 
mature mTECs as well as the miRNAs inducing the differentiation of one 
stage to the other might answer the questions. 
 
4.3 Usage of different approaches to find potential miRNAs 
To find potential miRNAs, which might be relevant for the development of 
immature mTECs to mature mTECs we first generated a list of 80 miRNAs, 
which shows the four subpopulations with the highest variance difference 
within their miRNA expressions. Afterwards we did a principle component 
analysis (PCA) where we could see in the first PC, PC1, that 63% of that 
component provides the uppermost difference. We picked 25 miRNAs from 
that narrowed list, thus increasing our chance to find miRNAs, which have a 
functional role in the mTEC development. To understand the importance of 
those miRNAs in our four subpopulations we lined those miRNAs according to 
our lineage sequence and found that most of them are increasing or 
decreasing during lineage progression, while some are fluctuating during the 
development. We also verified the existence of those miRNA candidates with 
qPCR, comparing wild type Black6 to Dicer KO mice. The results revealed 
that our miRNA candidates are non-existing or have a minimal expression 
level in Dicer KO mice. Thus those miRNAs we have picked are worth 
investigating.  
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The potential miRNA candidates, which we found as the most prominent 
ones, are the results of two steady-state models. However the mTEC 
development is a dynamic process. To investigate on steady state miRNAs is 
a good start, as it hasn’t been done before, but to go further in exploring 
dynamic miRNAs in the mTEC development would be more promising, as 
those will be influencing the development directly. Thus we will search for 
dynamic miRNAs by using a SCID mouse model and re-establishing the 
thymic crosstalk. As outlined before, SCID mice have an intact thymus but 
exhibit a blockade of mTEC development due to the lack of functional T-cells. 
A reconstitution of SCID mice with wildtype bone marrow can actually reverse 
this blockade. This approach has many advantages over other approaches, 
which have been used to study mTEC regeneration, such as use of irradiation 
or cyclophosphamide treatment all of which involve cytoablative techniques 
and therefore generate possible systemic effects or defects. In contrast, bone 
marrow reconstitution in SCID will be performed under physiological 
conditions, allowing us to measure the unperturbed response of the mTEC 
compartment to T cell-derived signals as well as to follow the expression of 
miRNAs during the reconstitution. Another important feature of this model is 
that the reconstitution is done in the intact adult thymus by adult bone marrow-
derived cells, resembling the adult thymus and their miRNA pool as the 
measured outcome will therefore reflect the dynamics of mTEC maintenance 
and lineage progression in the adult thymus, which might differ from the 
events taking place during embryonic development. 
We isolated bone marrow from wild type mice and injected them i.v. in SCID 
mice. Always a pair of 12 SCID injected and SCID wild type mice are kept 
under surveillance. The time slot for the FACS analysis and RNA isolation 
was 3, 4, 5, 7 and 8 weeks post transplantation. The time periods were 
selected based on experiments to determine the time period where mTECs 
might start developing and when the mTEC development process becomes 
stable (not shown). CD4 and CD8 T cells are generating already after 4 weeks 
post bone marrow transplantation while the four subpopulations can only be 
seen in week 5. Therefore it is interesting that immature mTECs need roughly 
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a week to be generated as the time shift between T cell generation and 
immature mTEC development was around a week. After we have isolated the 
RNA during the different time points we checked for the miRNA expression 
levels of our miRNA candidates. Interestingly we saw a very dynamic change 
of miRNA expression during the maturation process from the beginning until 
week 5. The levels between week 5 and week 8 did not show any differences 
(not shown). Thus we believe that the miRNAs we have picked might be 
relevant for the maturation process of immature mTECs especially the 
generation of the four subpopulations within the immature mTEC pool. Due to 
the low number of RNA in Sca-1, DP and DN, it was necessary to pool Sca-1 
with DP and CD24 with DN respectively. It was enough to see that those 
miRNAs we picked are not stable during the development and therefore could 
exclude non-relevant miRNAs. Ideally would be to have four separate 
samples but it would have been too pricy and too many animals to collect the 
amount needed.  
 
4.4 Discovery of a new reliable transfection method 
So far researcher have failed to find a liable method to transient transfect 
freshly isolated mTECs. Most researchers are using either a mouse line to 
check the loss and gain function of a certain miRNA or using mTEC cell lines 
to investigate miRNA functions. None of those two methods are practical as 
generating a mouse line with a certain miRNA is not cost effective and time 
consuming. Furthermore, cell lines do not resemble the microenvironment of a 
mouse itself. Therefore a new method needs to be established to do a wide 
range screening of miRNAs on mTECs in a short time manner. We tried 
lentivirus as a transfection method but did not proceed further even though we 
produce a high percentage of positive cells, around 80%, but the amount of 
living cells were extremely poor, around 25%, thus those cells were not 
capable to generate RTOCs or there were not enough cell numbers left to run 
further analysis. Afterwards we started to test with different transfection 
reagents and only one reagent was able to produce high numbers of positive 
cells. Not only we reached 73% of positive cells, the viability of mTECs was 
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around 88%. The next step was to transfect all mimics and antagomiRs 
individually in freshly isolated mTECs and then checked for their functionality 
by qPCR. An incubation of 14 hours was enough to increase miRNA level by 
mimics or decrease the miRNA level to a non-detectable level by antagomiRs. 
A shorter time than 14 hours were not checked as normally mimics and 
antagomiRs are recommended in the protocols to be incubated for at least 24 
hours. In our case we needed to reduce the incubation time as freshly isolated 
mTECs are not surviving for longer than 24 hours if not placed into a RTOC 
system. Though the incubation time was shorter than suggested the results 
we have achieved was evidently effective to induce miRNA changes.  
 
4.5 MicroRNA level changes influence the development of the four 
subpopulations 
Red-labelled immature mTECs were transfected with antagomiRs and mimics, 
respectively to see their relevance in the development of the four 
subpopulations. When we compared transfected cells with a negative control 
we indeed we saw significant shifts in the four subpopulations when we 
transfected immature mTECs with the following miRNA mimics and 
antagomiRs, respectively: miR-125a-3p, miR-125b-5p, miR-200c, miR205, 
miR-29a-3p, miR-34a-5p, miR-34b-3p, miR-709, miR-761, miR-877-3p and 
miR-92a-5p. The only miRNA, which failed to show any significant changes 
was miR-203. Surprisingly as miR-203 has been linked to epithelial 
differentiation along with miR-200 family and miR-205, but only miR-200c and 
miR205 showed a distribution change in the four subpopulations (Yi et al. 
2008), (Khan et al. 2015). The average distribution of the subpopulation DP 
was around 71.6% when cells were transfected with a negative control and 
23,7% transfected with a positive control that is a drop of cells in the DP 
population of 67%. When comparing the negative control and the DP 
population we could observe the lowest difference of 3% induced by miR-761 
mimic. The highest difference, 47%, is shown between the negative control 
and miR-709 mimic and miR-877 antagomiR. Five miRNAs did show a 
significant change when transfected either with a miRNA mimic or 
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antagomiRs, respectively. These were miR-29a, miR-34b-3p, miR-709, miR-
761 and miR-92a-5p. The distribution changes which each of the miRNA 
candidates have caused could only be seen as a whole and not how each of 
the miRNA interfered the development of each subpopulation. Due to the 
limited numbers of cells it was not possible to do such experiments. Therefore 
it would be worth investigating in those miRNA candidates generating a 
mouse line with the respective miRNA and to see the lost and gain function. 
There we could see the impairment of the development of each individual 
subpopulation, the generation of TRAs and mTEC development.  
 
4.6 Search for relevant mRNA-miRNA pairs 
Our collaborator in UCLA generated the list of mRNAs with their negatively 
correlated miRNA candidates. They used two different approaches to narrow 
down the list of potential candidates by looking first at the most negatively 
correlated miRNA-mRNA pairs. Then we searched if the pair has been 
already verified or published. In the list the miRNA-mRNA pairs have been 
mostly published such as Bak1 is reported to be a direct target of miR-125b 
(Chen et al. 2015), miR-125b targeting Arid3b (Akhavantabasi et al. 2012) or 
miR-34a regulates Bcl2 (Wang et al. 2017). The list was then further analysed 
and narrowed through an intensive search in genecards.org to see which 
mRNA might target important signalling pathways or are involved or reported 
to be involved in development, maturation or differentiation. All 34 mRNA 
targets are highly negatively correlated to our candidate miRNAs. Though it 
seems biased to select from a list of known miRNA-mRNA pairs but the 
chances to find functional miRNA-mRNA pairs are still not guaranteed.  
 
4.7 MiRNAs with functional effects  
We tested all 34 mRNA targets from our list and check for any changes in the 
four subpopulations by using siRNAs to downregulate their expression levels. 
Quickly we found four targets, which have shown a variation in the distribution 
of the four subpopulations. Therefore the entire experiment was done another 
time to verify the findings. Indeed those four mRNAs are showing a significant 
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change when compared to the negative control. The mRNA targets are Bak1, 
Mapk14, Foxp1 and Fam83e. Based on the p-value of Foxp1, which was 
0.04. But Bak1, Mapk14 and Fam83e have a p-value below 0.007, which give 
us more confident that those three mRNA targets are playing a significant role 
in the development of the four subpopulations. Nevertheless we did for all four 
targets a luciferase assay to confirm the negative correlation between the 
miRNA-mRNA pairs. All four were positive and showed that miR-125b-5p 
interacts with Bak1 and Mapk14, miR-125a-3p with Fam83e and miR-34a-5p 
with Foxp1. MiR-125a-3p, miR-125b-5p and miR-34a-5p have shown already 
very promising results when we transfected immature mTECs with either 
mimics or antagomiRs. MiR-125a-3p antagomiR shrunk the DP population 
from 71.6% to 43.5%, which is a decline of 39%. Whereas the miRNA mimics 
of miR-125b-5p and miR-34a-5p decreased the DP subpopulation to 61.4% 
and 57.1%, respectively. Unfortunately we could not find any promising 
targets for miR-709 and miR-877 as those miRNAs have shown very 
promising results. Both miRNAs provoked very significant changes in the four 
subpopulations; a drop in the DP population compared to the negative control 
was 12% with miR-709 antagomiR, 47% with miR-709 mimics and 47% with 
miR-877 antagomiR. Therefore an intensive investigation of those two 
miRNAs is worth as those two miRNAs are playing an important role to keep 
the immature mTEC pool intact.  
 
4.8 The new mRNA targets in immature mTECs and their potential 
involvement in the mTEC development 
MiR-34 family has been reported to play a role in regulating important targets 
in cell cycle progression, regulation of cell growth and anti-apoptosis. Foxp1 is 
a bona fide target of miR-34a and has been linked to play a crucial role in B 
cell development, especially in the early B lymphoid development (Rao et al. 
2010). Mir-125b-5p has been linked to repress its direct target Bak1, a pro-
apoptotic gene (Bayoumi et al. 2018) and is known to play a role in myeloid 
cell proliferation (Surdziel et al. 2011). Another important target of miR-125b is 
Mapk14 (Yao et al. 2016), which belongs to the Map kinases and are known 
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to play important role such as development, proliferation, differentiation and 
transcription regulation. Fam83 family has been linked to the Mapk signalling 
and has been identified as a driving force for epithelial cell transformation. 
Fam83e was found to drive mammary epithelial cell transformation (Cipriano 
et al. 2014). Our outcomes have shown that we have searched in the right 
direction as all four mRNA targets are linked to differentiation and 
development. To understand the importance of the miRNAs and the mRNA 
targets mouse models need to be generated and looked closer to the changes 
of mTEC maturation and expression of tissue restricted antigens.  
 
4.9 Interesting mRNA target for further investigation 
As a positive control we used let-7c-5p as it has been reported to correlate 
negatively to HMGA2. HMGA2 is a non-histone, which is ubiquitously 
expressed and has the feature as a chromatin protein to change the gene 
expression through chromatin modulation. The rational for using let-7c as a 
positive control was that the gene expression in immature mTECs is different 
compared to mature mTECs as well as the expression levels within the four 
subpopulations. A disruption of gene expression can induce a halt in the 
development within the four subpopulations. Interestingly the induction of let-
7c in the immature mTECs caused a significant change in the four 
subpopulations with a similar distribution in SCID, nude and Dicer KO mice. In 
this PhD we only investigated in the other miRNA candidates and used let-7c 
as a positive control as it has shown to induce changes in the development of 
the four subpopulations hence it makes sense to study further this miRNA in a 
mouse model to find their relevant targets in mTECs. Notably a group has 
found the importance of the miR-let-7 family in mTECs, especially in 
controlling the expression of tissue restricted antigens (Oliveira et al. 2016).   
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5 Concluding remarks and future 
perspectives 
 
In overall our results could increase the understanding of the involvement of 
miRNAs in the development of immature mTECs to mature mTECs. In this 
study we have added novel aspects to the developmental sequence of TECs 
as well as novel miRNAs and mRNA targets in TECs: 
 
1. In regards to the knowledge of the existence of the four subpopulations 
in neonatals and embryos, we expanded their lineage progression in 
adults (Sca-1 < DP < CD24 < DN < mature mTECs).  
2. We developed a new method to induce miRNA changes in freshly 
isolated primary mTECs via transient transfection.  
3. The miRNA and mRNA microarray data revealed numerous interesting 
miRNAs linked to the development of the four subpopulations to 
become mature mTECs. Those results were compared with the 
outcome of a dynamic SCID mouse model where we could track 
miRNAs during the development of mTECs, from the development of 
immature mTECs until mature mTECs. With the knowledge of both 
models we generated a list of miRNA and confirmed their relevance by 
overexpressing or downregulating those miRNA candidates. At the end 
we discovered 10 relevant miRNAs playing a role in the development of 
the four subpopulations. 
4. From those 10 potential miRNAs we found 4 mRNA targets, which 
seem to play a major role in the maturation step of the subpopulations 
and negatively controlled by three of our miRNA candidates.  
 
Mouse lines expressing candidate miRNAs should be generated to investigate 
the gain and loss of function of these miRNAs and the consequences in the 
thymus, on mTEC development and on the expression of tissue restricted 
antigens (TRAs).  Importantly for the clinical perspective those miRNAs and 
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their mRNA targets should be verified and characterized in immature mTECs 
using the human mTECs operating with a similar experimental approach.  
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